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General introduction
Arterial restructuring is an important limiting factor for the success rate of balloon angioplasty.
In recent years, a large number of articles point to an important role of collagen turnover in
arterial restructuring. However, our knowledge about the precise regulators of collagen turnover
remains incomplete. In order to develop specific inhibitors of arterial restructuring, it is crucial
to obtain a better understanding of the molecular pathways involved in collagen turnover and
to elucidate the function and regulation of proteins involved in collagen turnover. In this thesis,
we used subtraction PCR to identify new candidate proteins that are involved in arterial
restructuring. One of the identified proteins is the acute phase protein haptoglobin which is
normally produced in the liver. Arterial haptoglobin expression is potentially very interesting
as haptoglobin has been associated with aneurysm formation, angiogenesis and controlling
cathepsin and elastase activity. In this thesis, the expression, regulation and function of arterial
haptoglobin is investigated and related to arterial restructuring.
Arterial restructuring
Atherosclerosis is a multifactorial disease, being
recognized as the number one cause of mortality
in the western world. The formation of an
atherosclerotic plaque leads, together with
remodeling of the artery, to luminal shrinkage
and eventually to arterial obstruction. A widely
used treatment for occlusive atherosclerotic
lesions is percutaneous transluminal angioplasty
(PTA, balloon angioplasty), where an inflated
balloon compresses the plaque into the arterial
wall. However, restructuring of the arterial wall
(restenosis) occurs in 30-50% of the cases1-2,
thereby nullifying the benefit of balloon
angioplasty. Nowadays, 70% of the coronary
revascularizations involve the use of a stent, a
flexible metal tube that mechanically prevents
arterial shrinkage.
Arterial restructuring after balloon angioplasty
is determined by two different processes:
geometric remodeling of the artery and neointima
formation. Geometric remodeling is defined as a
structural change in total arterial circumference.
Enlargement of the artery compensates for lumen
loss due to neointima formation while shrinkage
of the artery (constrictive remodeling) accelerates
lumen narrowing. Neointima is formed in
response to arterial injury and consists of cell
migration and extracellular matrix accumulation.
Both human and animal studies demonstrated
that constrictive remodeling is the major
determinant of arterial restructuring3-4 and can
explain up to 70% of the observed lumen loss.
Arterial restructuring following balloon
angioplasty is a complex process that involves
cell proliferation, cell migration and remodeling
of the extracellular matrix. Although the
extracellular matrix is traditionally seen as an
inert scaffold, extracellular matrix turnover is a
prerequisite for arterial restructuring. Recent
studies have demonstrated that turnover of the
extracellular matrix regulates many cellular
processes that are also observed after balloon
angioplasty5. In general, there is enhanced
collagen synthesis and degradation in the arterial
wall within the first week after balloon
angioplasty, followed by a gradual accumulation
of collagen.
Arterial restructuring and collagen
synthesis
Since collagen type I and III are the most
abundant extracellular matrix proteins in arteries
and play an essential role in maintaining the
structural integrity of the artery6, the effects of
balloon angioplasty on the turnover of these two
types of collagen have been thoroughly investi-
gated in various animal models7-8. Synthesis of
collagen type I and III is induced early after
arterial injury and mainly localized in the
adventitial layer and newly formed neointima9-
10. This increase in collagen synthesis is followed
by a gradual accumulation of collagen, coinciding
with an increase in cross-sectional vessel area.
The observed delay in collagen accumulation is
probably accounted for by enhanced collagen
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degradation in the same time-period as increased
collagen synthesis11.
Although it is generally believed that intact
collagen fibers form a structural barrier for cells
to prevent cell migration12, there is increasing
evidence that active collagen synthesis plays an
important role during cell migration. Increases
in collagen synthesis coincide with cell migration
towards the neointima and intact collagen can
promote cell migration by functioning as a
chemotactic factor13-14 or by providing the correct
substrate for cell migration15. In addition,
inhibition of de novo collagen synthesis impairs
cell migration16, implying that only newly
synthesized collagen is able to serve as a suitable
substrate for cell migration.
Changes in arterial collagen content after balloon
angioplasty may have pronounced effects on the
arterial remodeling response. Collagen content
increases after balloon angioplasty and the
accumulation of collagen has been associated
with constrictive remodeling and the severity of
restenosis after balloon angioplasty17. As
collagen type I provides structural strength to
the artery, the accumulation of collagen type I in
the adventitial layer suggests a role in the
resistance of the artery to remodeling. This is
supported by the association between decreased
adventitial collagen content after MMP
inhibition and the observed inhibition of constric-
tive remodeling in favor of arterial enlargement18-
19.
Another mechanism through which collagen
accumulation may influence constrictive
remodeling involves the crosslinking of newly
synthesized collagen by lysyl oxidase into
compact collagen fibers. Several studies
demonstrated that lysyl oxidase is involved in
the contraction of collagen matrices20-21.
Moreover, reduced lysyl oxidase activity is
associated with aortic aneurysm development22-
23 whereas increased lysyl oxidase activity has
been implicated in the pathogenesis of atheroscle-
rosis24.
Arterial restructuring and collagen
degradation
Degradation of collagen requires the action of
matrix metalloproteinases (MMPs), a family of
zinc-containing endopeptidases that collectively
are capable of degrading all components of the
extracellular matrix. With the exception of
stromelysin-325, MMPs are secreted as inactive
zymogens that are cleaved into mature active
enzymes. MMP activity is strictly regulated at
several levels including gene transcription,
zymogen activation and binding to tissue
inhibitors of MMPs (TIMPs).
Increased MMP activity influences both
neointima formation and constrictive remodeling
after balloon angioplasty. Collagen degradation
after arterial injury induces the expression of
many genes that are associated with restenosis
and normally suppressed by polymerized
collagen26. Expression and activation of MMPs
is increased early after balloon angioplasty with
peak levels within the first week 11, 27-29 and
accompanied by increased expression levels of
TIMPs29. Increased MMP activity is associated
with the development of arterial restructuring 27,
30-31 whereas MMP inhibition prevents
constrictive remodeling and subsequent luminal
narrowing18, 32-33.
The relation between MMPs and neointima
formation has been investigated extensively and
mainly linked to increased cell migration after
arterial injury. In vitro studies have demonstrated
that cell migration depends on active collagen
synthesis16 as well as collagen degradation12, 34-
35. Cell surface localization of several MMPs
allows highly localized and tightly controlled
proteolysis of the extracellular matrix, thereby
enabling cell migration35-36. Furthermore, in vivo
studies have shown an association of active
MMP-227, 30 and MMP-937 with smooth muscle
cell migration into the intima and that inhibition
of MMPs results in a nearly complete inhibition
of smooth muscle cell migration into the intima.
The initial effects of MMP inhibitors on
neointima formation looked promising at early
timepoints after arterial injury and were related
to decreased migration of smooth muscle cell
towards the neointima. However, increased cell
proliferation in the neointima was responsible
for a catch-up in neointimal area at later time-
points38-39. Thus, the beneficial effect of MMP
inhibition on neointima formation seems only
temporary.
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Arterial remodeling has been compared to scar
contraction which also requires restructuring and
degradation of the extracellular matrix. Several
studies have linked the expression and activity
of several MMPs to either arterial enlargement40-
41 or shrinkage33 of the artery. In contrast to the
large number of data that describe the role of
MMPs in neointima formation, data regarding
the involvement of MMPs in arterial remodeling
are limited. Increased MMP-9 activity is asso-
ciated with arterial enlargement during aneurysm
formation42 and after arterial injury37. Moreover,
aneurysm formation can be blocked by MMP
inhibitors43 or TIMP-1 overexpression44 and
constrictive remodeling after balloon angio-plasty
can be reduced by MMP inhibition18, 33.
Inhibition of collagen turnover
Due to the essential role of collagen turnover in
arterial restructuring, inhibition of collagen
synthesis or degradation may have beneficial
effects on the success rate of balloon angioplasty.
Collagen synthesis can be blocked at several
levels including gene expression, triple helix
stability and fiber formation. Although some
studies provided promising results for the
prevention of arterial restructuring45-47, other
studies demonstrated that collagen synthesis
inhibition is not always beneficial48.
Inhibition of collagen degradation has become
the main focus of attention to prevent arterial
restructuring. MMP activity can be blocked in
various ways, either by reduction of the levels
of active MMP or by direct inhibition of MMP
activity. In the past, most studies used synthetic
broad spectrum MMP inhibitors that bind to the
zinc atom at the active center, thereby
inactivating the enzyme. Recently, also the effect
of TIMP overexpression has been investigated49-
50 which resulted in the reduction of neointimal
lesions after arterial injury. However, similar to
the synthetic MMP inhibitors, TIMPs are
multifunctional and have diverse activities that
are not only related to degradation of the extra-
cellular matrix51. In general, MMP inhibition
results in less cell migration towards the intima
and decreased collagen accumulation, thereby
attenuating neointima formation and arterial
remodeling.
Subtraction PCR
Despite the overwhelming evidence that collagen
turnover is essential during arterial restructuring
after balloon angioplasty, inhibition of collagen
turnover has provided little insight into the role
of individual proteins as most studies used broad
spectrum inhibitors that exert their effects on
multiple proteins. Thus, our knowledge about
the precise regulators of collagen synthesis and
degradation remains incomplete and makes it
essential to elucidate the function and regulation
of individual proteins involved in the collagen
turnover pathways.
To facilitate the discovery of novel, differentially
expressed genes between different tissues of
interest, a variety of methods have been
developed including differential display PCR52,
RNA fingerprinting53, suppressive subtraction
PCR54 and DNA microarrays55. Although most
researchers focus on DNA microarrays, this
technique has several disadvantages. The major
disadvantage is that microarrays generally cover
only the most common model systems like
human, mice and yeast. Thus, DNA microarrays
are not suitable for the identification of novel,
differentially expressed genes in animal models
such as the rabbit or pig. In addition, more
sensitive techniques like the subtraction PCR
allow the detection of sequences that have low
expression levels and will not be detected using
a microarray.
In this thesis, subtraction PCR is used as an
open approach to identify novel, differentially
expressed genes involved in arterial restructur-
ing. The subtraction PCR is based on the selec-
tive amplification of genes that are expressed in
one mRNA population but reduced or absent in
another. The method has proven to effectively
enrich differentially expressed genes without
prior knowledge about gene expression patterns
or functional and biochemical protein character-
istics.
Theoretically, balloon dilated arteries provide the
best material for the identification of genes
involved in arterial restructuring. There are,
however, some practical disadvantages about the
use of balloon dilated arteries in a subtraction
PCR. Arterial restructuring is a multifactorial
process that is determined by neointima forma-
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tion as well as geometric remodeling, making it
very difficult to determine whether newly
identified proteins are involved in only one of
these processes or in both. Compared to balloon
dilated arteries, the rabbit flow ligation model
represents a simplified model to focus on arterial
remodeling without the interference of neointima
formation. Hence, we used the rabbit flow ligation
model as the basis for a subtraction PCR to
identify novel, differentially expressed genes that
are involved in arterial remodeling and collagen
turnover.
Identification of novel genes involved in
arterial restructuring
The subtraction PCR was performed with
cDNA from shrunken and control rabbit arteries
(respec-tively flow decrease and normal flow),
resulting in a subtraction library of approximately
500 clones that were overexpressed in the
shrunken arteries. Ninety-six of these clones were
randomly selected for verification using dot blot
analysis (figure 1). Initial screening indicated that
30 clones were potentially differentially ex-
pressed although sequence analysis revealed that
several of the clones represented the same gene.
Thus, from the original 96 clones, 11 genes with
known sequences and 9 genes with unknown
sequences were identified as being differentially
expressed (table 1).
Although genes with unknown sequences are
potentially very interesting, the lack of, for
example, antibodies and knockout mice makes it
very difficult to identify functional relations
between these genes and arterial remodeling.
Therefore, we mainly focussed on genes with
known sequences. These genes can be classified
into two groups: 1) genes previously described
to be expressed in arteries (e.g. fibronectin56 and
tenascin57) and 2) genes that were not known to
be expressed in arteries (e.g. FHL-1 and hapto-
globin). Differential expression of candidate genes
was further verified by Northern blot analysis,
quantitative PCR and western blotting.
One of the identified genes using the subtraction
PCR was haptoglobin (figure 2). Haptoglobin is
potentially very interesting since it was not
known to be expressed in the arterial wall. In
addition, previous studies implied a role for hap-
toglobin in atherosclerosis or related processes
like angiogenesis, extracellular matrix degradation
and modulation of the immune system. There-
fore, we focussed on haptoglobin and investi-
Figure 1. Dot blot analysis of clones generated by subtraction
PCR
Two identical dot blots were made by transfer of cDNA from
clones to nitrocellulose membranes. The dot blots were hybridized
with a 32P labeled probe of the control minus flow decrease library
(left panel) and the flow decrease minus control library (right
panel). Clones with at least a 2-fold difference in expression
between the two different probes (for example C1, D4, G7 and
F10) were selected for further analysis.
Table 1. Clones identified using subtraction PCR
Figure 2. Multiple alignment of rabbit haptoglobin (clone R1045)
with monkey, human, mouse and rat haptoglobin
Grey boxes indicate identity with R1045.
clone sequence clone sequence 
R1002 hyaluronan R1076 EST 
R1003 elongation factor 1 R1078 EST 
R1004 EST R1082 EST 
R1010 hevin-like protein R1084 EST 
R1019 FHL-1 R2005 EST 
R1030 cytochrome oxidase R2014 fibronectin 
R1033 EST R2018 alpha SMC actin 
R1045 haptoglobin R2027 gamma SMC actin 
R1054 EST R2025 EST 
R1070 lumican R2041 tenascin 
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gated arterial haptoglobin expression, regulation
and function during arterial remodeling.
Haptoglobin synthesis
Until recently, the liver was thought to be the
major site of haptoglobin synthesis. However,
haptoglobin is also expressed at basal levels in
extrahepatic tissues and expression can be in-
duced in various tissues by lipopolysaccharide
(LPS)58-59. Haptoglobin expression is mainly regu-
lated at the transcriptional level by interleukin-6
(IL-6) although expression of haptoglobin can
also be induced by IL-1, tumor necrosis factor
(TNF) and glucocorticoids60.
Haptoglobin is synthesized as a single poly-
peptide (figure 3) that contains both the non-
glycosylated α-chain and the glycosylated β-
chain of haptoglobin61. Posttranslational cleavage
results in the formation of single α- and β-chains
that are subsequently linked by disulfide bridges
to form mature haptoglobin (α2β2)62.
Haptoglobin function
According to the amino acid sequence,
haptoglobin is homologous to serine proteases
of the chymotrypsinogen family63. This
homology is further supported by similarities in
posttranslational processing between hapto-
globin and tissue-type plasminogen activator64.
However, haptoglobin contains a small insertion
in the region corresponding to the methionyl loop
of serine proteases and a replace-ment of two of
the active-site amino acids typical of the serine
proteases63. Together, these alterations result in
homologous proteins with different biological
functions.
Haptoglobin has a strong non-covalent binding
capacity for hemoglobin and the formation of
haptoglobin-hemoglobin complexes is believed
to be important for the hepatic clearance of
hemoglobin from the serum. The condition of
ahaptoglobinaemia is, however, clinically silent65.
Furthermore, haptoglobin knockout mice are via-
ble and have no impaired hemoglobin clearance66,
indicating that hepatic clearance of hemoglobin
is not an essential function of haptoglobin. The
physiological role of haptoglobin-hemoglobin
complexes is, however, not restricted to hemoglo-
bin clearance. The antibacterial properties of
haptoglobin depend on capturing hemoglobin-
bound iron67 and the antioxidative role of hapto-
globin is related to its binding to hemoglobin
which can act as a strong pro-oxidant68-69. Func-
tions of haptoglobin that are not related to the
binding of hemoglobin include modulation of the
immune system70-71, stimulation of angioge-
nesis72 and inhibition of cathepsin B73 and elastase
activity74.
Haptoglobin polymorphism
In humans, the haptoglobin gene is characterized
by a polymorphism with two common alleles for
the α-chain (Hpα1 and Hpα2), resulting in three
main phenotypes: Hp 1-1, 2-1 and 2-2. The
Hpα1 allele can be subdivided into two groups,
a fast (Hpα1F) and slow (Hpα1S) form, that
differ slightly in amino acid composition,
resulting in different electrophoretic mobility’s75.
The Hpα2 allele contains a unique nonhomo-
logous crossing-over in a part of the Hpα1F and
Hpα1S alleles76 and can only be found in man.
Haptoglobin proteins form multimers due to
disulfide bridges between two α-chains and the
size of the multimers is determined by the α-
chain phenotype77 (figure 4). The Hpα1-chain
is monovalent and can only form a disulfide bridge
with another α-chain resulting in a haptoglobin
tetramer (α1β)
2
. In contrast, the Hpα2-chain is
divalent and can form two disulfide bridges. Thus,
Hpα2-chains can bind to either Hpα1- or Hpα2-
chains to form large multimers ((α
1
β)
2
-(α
2
β)
n
 in
Hp2-1 phenotypes and (α
2
β)
n
 in Hp2-2
phenotypes).
Besides the polymorphism, an additional hapto-
globin gene has been isolated which shares a high
degree of nucleotide sequence homology with
Figure 3. Schematic representation of the haptoglobin gene, RNA
and protein
e1-e7 indicate exons, i1-i6 indicate introns.
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Hpα1. This haptoglobin-related gene (Hpr) is
thought to be evolved by gene duplication and
subsequent divergence78 and plays an important
role in killing trypanosomes79.
Haptoglobin in cardiovascular disease.
Haptoglobin phenotype was generally deter-
mined as a genetic fingerprint for the use in
forensic medicine. More recently, the posses-
sion of a certain haptoglobin phenotype has been
associated with a variety of common diseases,
suggesting that there are functional differences
between the haptoglobin phenotypes80-81.
Cardiovascular disease is one of these diseases
in which haptoglobin phenotype plays a role.
There is a weak association between Hp2-1
phenotype and abdominal aortic aneurysm
susceptibility74, 82-83 which is thought to depend
on increased elastase activity. Atherosclerosis
and restenosis are, in contrast, associated with
the Hp2-2 phenotype. Patients with this
phenotype are more likely to develop restenosis
after balloon angioplasty84, stenting85 or coronary
surgery86. Moreover, there appears to be a
gradient in the risk, with Hp2-1 individuals
having an intermediate risk. Oxidative stress has
been implicated in the initiation and pathogenesis
of  atherosclerosis87 and might explain the
prevalence of Hp2-2 phenotype in atheroscle-
rosis as Hp1-1 appears to have better anti-
oxidative capacity compared to Hp2-288-89. Thus,
specific haptoglobin phenotypes may offer pro-
tection against the development or progression
of cardiovascular diseases.
Figure 4. Schematic representation of the structural differences of
haptoglobin multimers as determined by haptoglobin phenotype
Outline of the thesis:
The aim of this thesis is to gain more insight in
the arterial expression and function of hapto-
globin during arterial restructuring. In chapter 2,
subtraction PCR identifies arterial haptoglobin
expression after sustained flow changes and the
role of haptoglobin in cell migration and arterial
restructuring is inves-tigated. In chapter 3, the
regulation of arterial haptoglobin expression af-
ter sustained flow changes is investigated.
Chapter 4 describes the local expression of hap-
toglobin in arthritic and oncological tissues, two
pathological processes characterized by exten-
sive tissue remodeling and cell migration. Chapter
5 describes the existence of unique arterial hap-
toglobin β-chains, implying functional differences
between arterial and liver haptoglobin. In chap-
ter 6, the association between serum haptoglobin
glycosylation patterns and atherosclerotic dis-
ease is investigated.
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The acute phase protein haptoglobin is a cell migration factor
involved in arterial restructuring.
D.P.V. De Kleijn1, 2, M.B. Smeets1, 2, P.P.C.W. Kemmeren1, S.K. Lim3, B. van Middelaar1, E. Velema1,
A. Schoneveld1, 2, G. Pasterkamp1, 2, C. Borst1
1 Experimental Cardiology Laboratory, University Medical Center, Utrecht, the Netherlands.
2 Interuniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, the Netherlands.
3 Cardiovascular Research Institute, NUMI, The National University of Singapore, Singapore.
Collagen turnover and cell migration are fundamental aspects of arterial restructuring. To
identify mRNAs involved in blood flow-induced arterial restructuring, we performed subtraction
polymerase chain reaction and found expression of haptoglobin mRNA in arterial fibroblasts
of rabbit arteries. Haptoglobin is highly expressed in liver, but it’s arterial expression and
function are unknown. In vitro studies revealed that stimulation of haptoglobin expression
by lipopolysaccharides in mice fibroblasts stimulated migration of wild type fibroblasts, but
had no effect on migration of haptoglobin knockout fibroblasts. In vivo studies showed that
flow-induced arterial restructuring was delayed in haptoglobin knockout mice. This new
function of haptoglobin might be explained by facilitating cell migration through accu-
mulation of a temporary gelatin matrix because cell culture showed that haptoglobin is
involved in the breakdown of gelatin. We conclude that haptoglobin is highly expressed in
arterial tissue and is involved in arterial restructuring. This new haptoglobin function may
also apply to other functional and pathological restructuring processes such as angiogenesis,
tissue repair and tumor cell invasion.
Introduction
Proteolytic degradation and synthesis of the
extracellular collagen matrix and cell migration
are critical steps during tissue remodeling in
normal and pathological processes, including
wound healing, inflammation, tumor invasion and
metastasis1-2. Tissue remodeling in arteries may
induce a structural change in total arterial circum-
ference and is a major determinant of luminal
narrowing after balloon angioplasty3-5, in athero-
sclerosis6-7, and during sustained changes in blood
flow8. Strength, stiffness, size and shape of the
arterial wall are mainly determined by fibrillar
collagen (type I and III) which is predominantly
located in the adventitia9. Collagen breakdown
by matrix metalloproteinases (MMPs) is
essential for arterial restructuring to occur.
Administration of MMP inhibitors can prevent
arterial enlargement induced by a flow increase10
as well as arterial shrinkage after balloon angio-
plasty11-12.
Migration of adventitial fibroblasts and medial
smooth muscle cells (SMC) is also a fundamental
aspect of arterial restructuring. Translocation of
cells from the adventitia or media to the intima
is considered to be critical to the development
of atherosclerosis13 and restenosis after injury14.
Locomotion of SMCs requires newly synthesized
collagen, implicating a mechanism whereby
integrin clustering and linkage to the
cytoskeleton are required for effective cell
movement15. Although collagen turnover and cell
migration are regarded as essential processes of
arterial restructuring, their components and
regulatory mechanisms are still unclear.
The aim of this study was to identify components
of collagen turnover and cell migration during
flow-induced arterial restructuring. By using
subtraction polymerase chain reaction (PCR) in
rabbits, we found increased haptoglobin mRNA
levels in adventitial fibroblasts. In vitro and in
vivo assays showed that haptoglobin promoted
cell migration and that in haptoglobin knockout
mice, arterial restructuring was delayed
compared to wild type mice. Cell culture showed
that haptoglobin is involved in the degradation
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of gelatins, the intermediate breakdown products
of collagen. Taken together, this study shows that
haptoglobin is expressed in arteries and is invol-
ved in arterial restructuring, probably through
the formation of a temporary gelatin-based
matrix that enhances cell migration.
Materials and Methods
Animals
Rabbits: Surgical interventions to increase or decrease flow were
performed in the right carotid and femoral arteries of each New Zealand
White rabbit (Broekman Charles River, 3-3.5 kg). The untreated left
femoral arteries served as control. Rabbits were anesthetized by
intramuscular injection of methadon (0.15 ml) and Vetranquil (0.15 ml)
followed by intravenous injection of etomidate (1 mg/kg) and ventilation
with N
2
O:O
2 
(1:1) and 0.6% Halothane. An incision was made in the
neck to expose the right common carotid artery and jugular vein. For the
femoral artery and vein, an incision was made in the upper leg.
To increase the flow by about a factor 10, a side-to-side anastomosis was
made between the artery and the vein resulting in arterial enlargement16.
To reduce flow by about half, a partial ligation was made by placing a
constricting suture around the artery until flow was reduced to at least
60% of the initial value, resulting in arterial shrinkage16. Rabbits were
killed 1, 2 and 7 days after the operation. At operation and termination,
blood flow was measured by using a transit time flow probe (Transonic
System Inc.). Arterial segments to be analyzed were dissected from the
artery not closer than 1.5 cm from the operation area.
Mice: The haptoglobin knockout mice had been back-crossed into the
wild type mice BALB/c background for at least 12 generations at the
time of the experiment. Female wild type BALB/c mice and BALB/c
mice with a haptoglobin null mutation17 were anesthetized by using 0.05
ml/10 g body weight of a cocktail (1 part Hypnorm, 1 part Midazolam, 2
parts distilled water). The right common carotid artery was ligated as
described by Kumar and Lindner18. Animals were killed at 5, 8 and 20
days after ligation. Before the arteries were harvested, they were perfused
via the left ventricle for 3 min with phosphate buffered saline (PBS) plus
10-4 M sodium nitroprusside followed by a 3 min perfusion with 4%
paraformaldehyde in PBS plus 10-4 M sodium nitroprusside at 99 ml/h.
After the harvest, the arteries were fixed in 4% paraformaldehyde in PBS
for several days before being embedded in paraffin. Eight or more
serial sections (6 µm), spanning most of the vessel segment, were cut
and stained with elastin von Gieson and hematoxilin-eosin for
morphometry. All sections were analyzed for morphometry using the
SIS analysis software package.
The investigation conformed to the Guide for the Care and Use of
Laboratory Animals (NIH publication No.85-23, 1985) and was approved
by the ethical committee on animal experiments of the Faculty of Medicine,
Utrecht University, and University of Singapore.
Extraction of RNA and protein
After collection of the rabbit artery, a small part was dissected and fixed
for 2 h in 4% paraformaldehyde at room temperature (RT), followed by
an overnight (o/
n
) incubation at 4 oC in 15% sucrose in PBS. Samples
were embedded in Tissue Tec (Sakura Fineteck) and stored at –80 oC
until use for in situ hybridization or immunohistochemistry. The remaining
artery was frozen and ground with a pestle and mortar in liquid nitrogen
until a fine powder was obtained and was used for Tripure (Roche)
isolation of RNA and protein. After collection of the mouse carotid
artery, the complete artery was used for RNA and protein extraction.
Extraction and purification of total RNA and protein was performed
according to manufacturer’s protocol.
Quantitative PCR
PCR amplification was performed for the mouse carotid arteries and rabbit
carotid arteries and liver with the I-cycler iGTM Real Time PCR (Bio-
rad). Each reaction contained 14 µl of cDNA, 200µM dNTP, 1x reaction
buffer (InVitrogen) containing 1:80,000 Cybergreen (Bio-rad), 2.5 U of
Taq DNA polymerase (InVitrogen) and each primer at 1 µM. Quantities
were determined by comparison with known quantities of the cloned
PCR products representing the target mRNAs. Data were corrected for
the amount of 18S mRNA that was used as an internal standard.
The following oligonucleotides were used as primers: mouse haptoglobin
(forward 5’-AAAAACCTCTTCCTGAACCAC-3’, reverse 5’-AACGAC
CTTCTCAATCTCCAC-3’), mouse 18s (forward 5’-TCAACACGGGAA
ACCTCAC-3’, reverse 5’-ACCAGACAAATCGCTCCAC-3’), rabbit
haptoglobin (forward 5’-GAAGCAGTGGGTGAACAAGG-3’, reverse
5’-TGACAAGATTGTGG CGGGAG-3’), rabbit 18s (forward primer 5’-
TCAACACGGGAAACCTCAC-3’, reverse primer 5’-ACAAATCGCTC
CAGCAAC-3’).
Subtraction PCR, library screening and sequence analysis
Total RNA, isolated from one femoral artery after flow reduction and
from its contralateral artery, was converted into cDNA and amplified
using the SMART PCR cDNA Synthesis kit (Clontech). Samples were
prepared for the PCR-Select cDNA subtraction kit according to
manufacturer’s protocol. Subtracted cDNA was then ligated in pGEM-
T-easy (Promega) and transformed in Xl1blue by using supercompetent
cells (Stratagene). White colonies were picked and individually grown
o/
n
. Double-stranded plasmid DNA was isolated (Qiagen) and, after
1:100 dilution in water, spotted on four nylon membranes (Hybond-N,
Amersham), resulting in four identical membranes.
After baking proceeded for 2 h at 80 oC, each blot was hybridized with a
different cDNA probe: unsubtracted cDNA of the flow reduced artery,
unsubtracted cDNA of the control artery, subtracted cDNA of flow
reduction minus control and subtracted cDNA of control minus flow
reduced artery. Clones were selected for sequence analysis when they
showed a large difference between the two subtracted probes and no or a
low signal for the unsubtracted probes.
Sequence analysis was performed on both strands using the T7 Sequenase
2.0 sequencing kit (Amersham).
Northern and Western blotting
For Northern blotting, hybridization occurred at 65 oC in Easy-hyb
hybridization solution (Stratagene) for 1 h in a hybridization oven. The
membrane was washed in 0.1 x standard saline citrate (SSC), 0.1% sodium
dodecyl sulfate (SDS) at 65 oC for 10 min.
For Western blotting, the amount of protein was determined by using the
Biorad DC Protein assay. Protein samples (8 or 3 µg/lane for the mice
carotid arteries) were separated on a SDS polyacrylamide gel (8%). After
electrophoresis, the gel was blotted to Hybond-C (Amersham) in blotting
buffer (3.03 g /L Tris 14.4 g/L Glycine, 20% methanol). After the blotting,
the gel was blocked o/
n
 in PBS plus 0.1% Tween 20 (PBST) and 5% non-
fat dry milk (Protifar, Nutricia). Incubation with the first antibody (goat-
α-human collagen 1:1000, SBA or goat-α-human haptoglobin 1:4000,
ICN) occurred in PBST plus 5% Protifar for 1 h at RT followed by washing
(three times for 5 min each time) with PBST. Incubation was continued
with rabbit-α-goat biotin (1:1000, DAKO) for 1 h at RT in PBST plus 5%
Protifar followed by washing (three times) with PBST. After this,
incubation with streptavidin-peroxidase (1:2000, Southern Biotechnolo-
gy) occurred at RT for 1 h in PBST plus 5% Protifar. The blot was
washed two times with PBST. Bands were visualized by using the
enhanced chemiluminescence kit (Amersham).
In situ hybridization
Linearized R-1045 in PGEM T-easy was used as a template to obtain
digoxigenin (Dig, Roche) labeled RNA probes. Arterial segments were
cut into 8 µm sections and were transferred to Superfrost plus slides
(Menzel Glazer) and stored at –80 oC until use.
After the sections were defrosted, they were treated with 0.2 M HCl for
20 min at RT, washed three times with PBS for 5 min and treated with
proteinase K (Roche, 10 µg/ml) for 10 min at 37 oC in PBS. The sections
were then washed with PBS and fixed with 4% paraformaldehyde for 5
min at RT and treated twice for 5 min with acetic anhydride in
triethylacetate (TEA, 185 µl acetyl anhydride in 0.1 M TEA). Sections
were subsequently washed twice in 2 x SSC for 5 min at RT, followed by
5 min in 2 x SSC/50% formamide at 37 oC.
For prehybridization, 100 µl of hybridization mix (50 % formamide,
1mg/ml tRNA, 1 x Denhardts, 10% dextrane sulfate, 4 x SSC) was added
to the slide and the slide was incubated 1 h at 46 oC. A Dig (1 µl)-labeled
RNA probe was added, and hybridization continued o/
n
 at 46 oC.
After hybridization, sections were washed in 0.1 x SSC at 45 oC for 15
min, followed by RNAse treatment (40 µg/ml RNAse A, 1 mM EDTA
pH 8, 2 x SSC) for 15 min at RT, and then sections were washed again in
0.1 x SSC at 45 oC for 15 min. Before detection, sections were rinsed
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with 2 x SSC and 100 mM Tris pH 7.4 in 150 mM NaCl at RT. Detection
was performed according to manufacturer’s protocol.
Immunohistochemistry
Immunohistochemistry was performed with sections treated according
the aforementioned method and used after in situ hybridization. Sections
were fixed for 10 minutes in acetone containing 0.03 % H
2
O
2
 to block
endogenous peroxidase. Next, sections were incubated with 10% normal
goat serum for 30 minutes (RT) and, in addition, were incubated with 5
µg/ml mouse-α-vimentin monoclonal antibody (Sigma) o/
n
 at 4°C in
PBS/0.1% bovine serum albumin (BSA). After o/
n
 incubation, sections
were rinsed in PBS (three times for 5 min) and were incubated with 1
µg/ml goat-α-mouse peroxidase polyclonal antibody (DAKOpatts) in
PBS/1% BSA containing 1% normal rabbit serum (1 h, RT). Sections
were next rinsed in PBS (three times for 5 min). To visualize the
peroxidase, sections were treated for 10 min with a sodium acetate
buffer containing 0.4 mg/ml 3-amino-9-ethylcarbazole substrate.
Mouse primary fibroblasts
Mouse primary fibroblasts were prepared as previously described19. Mouse
primary fibroblasts were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (InVitrogen) with 1x MEM nonessential amino acids
(InVitrogen), 3.7 µl/500 ml β-mercaptoethanol, 100 U/ml penicillin,
100 µg/ml streptomycin and 20% fetal bovine serum (FBS) (InVitrogen).
Genotyping was done as described earlier17.
Migration was studied by using uncoated transwell culture chambers
(Costar 3422) with approximately 20,000 cells per chamber. Incubation
of cells with 10 ng/ml lipopolysaccharide (LPS) started 24 h before the
migration assay and was continued during the assay. Control cells were
incubated in the same media without LPS. Migration was continued for
20 h without chemoattractant according to manufacturer’s protocol. The
cells were counted as migrated cells when they migrated and attached to
the bottom well culture dish.
Primary human adventitial fibroblasts
A small part of the thoracic aorta was dissected from human donor and
recipient hearts during heart transplantation. The adventitial layer was
dissected from the aorta and rinsed several times in PBS, and cells were
isolated by using collagenase. Cells were cultured in DMEM (InVitrogen)
supplemented with L-glutamine, 100 U/ml penicillin, 100 µg/ml
streptomycin and 10% FBS (InVitrogen) and were used throughout
passages two to four.
Cell culture
Human arterial SMCs (American Type Culture Collection: CRL 1999,
passage 22-26) were used because they produce only small amounts of
haptoglobin (data not shown). Cells were grown in Ham’s F12 medium
with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 10 mM HEPES,
10 mM TES, 50 µg/ml ascorbic acid, 10 µg/ml insulin, 10 µg/ml
transferrin, 10 ng/ml sodium selenite, 30 µg/ml endothelial cell growth
supplement and 10% FBS. During experiments, 1% FBS or mouse serum
was used. After this, the SMC culture medium with or without haptoglobin
was harvested and used for Western blotting with an antibody directed
against human collagen I and III (Sigma).
MMP-2 activity, gelatinase assay, and zymography
MMP-2 activity assay: Different concentrations of haptoglobin (Sigma)
or BSA (Bio-rad) were added to 1 ng of activated MMP-2 or MMP-9 by
using the MMP-2 or MMP-9 activity assay (Amersham). The assay was
performed according to manufacturer’s protocol.
Gelatinase assay: Polyacrylamide gels (8%) containing 1 mg/ml gelatin
(Sigma) and Brij solution (0.05 M Tris-HCl pH 7.4, 0.01 M CaCl
2
, 0.05%
Brij 35 (Sigma)) were used, in which F12 medium or 10-6 M collagen I
(Biogenesis) or 10-6 M haptoglobin (Sigma) or marimastat (100 ng/ml,
British Biotech) were added to the gels. Samples of 1 µl of purified
MMP-2 or MMP-9 (Biogenesis) were spotted on the gel in different
concentrations and the gel was incubated at 37 oC for 8 h. The gel was
then stained with Coomassie brilliant blue (25% methanol, 15% acetic
acid, 0.1% Coomassie brilliant blue) for 1 h at RT, followed by destaining
(25% methanol, 15% acetic acid) for approximately 30 min. MMP-
activity was quantified by the amount of gelatin degradation (optical
density/mm2) using the Gel Doc 1000 system (Bio-rad). Zymography:
Zymography was performed as described earlier16 with 5 µl of medium
from heterozygous or knockout murine embryonic fibroblasts.
Statistics
Data are presented as mean ± standard deviation. Student’s t test plus a
Bonferroni correction was used for differences between mean values.
P<0.05 was considered as statistically significant.
Results
Subtraction PCR with rabbit mRNA isolated
from the partially ligated femoral artery (blood
flow decrease) and its contralateral artery
(unchanged blood flow) revealed 30 clones
encoding 20 different mRNAs. Clone R1045
with a sequence of 647 bp was identified as a
known protein. The open reading frame coded
for a partial protein of 197 amino acids (EMBL:
AJ250102) with a high identity to haptoglobin
reported previously for the monkey, human,
mouse and rat haptoglobin (85%, 84%, 82% and
80%, respectively).
Localization of haptoglobin in rabbit arterial
wall
Nonradioactive in situ hybridization showed
clear staining of a large number of cells in the
adventitial layer of the carotid artery at 1 day
after blood flow increase (figure 1A), close to
the external elastic lamina (figure 1C). No stai-
ning was found in the sense control (figure 1B)
and in naïve arteries (not shown). Interestingly,
a few cells containing haptoglobin mRNA were
also found in the medial layer (figure 1D), which
suggests migration of cells from the adventitia to
the media.
To identify the haptoglobin-producing cell type,
we performed double staining of haptoglobin
mRNA and vimentin to discriminate fibroblasts
from macrophages. Figure 1E demonstrates the
black staining of haptoglobin mRNA, whereas
figure 1F shows, at another depth of field, the
more prominent red vimentin staining.
Haptoglobin expression in rabbit tissue, rabbit
arteries after blood flow changes, and human
cells
To determine whether the same haptoglobin
mRNA was expressed in artery and liver, a tissue
blot (figure 2A) was used to show the bands of
the same size in carotid artery and liver. Quantita-
tive real-time PCR was used to determine relative
amounts of haptoglobin mRNA in arteries and
liver. This assay showed that 200 ng of total
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RNA of a control carotid artery contained 2±4%
(n=4) of liver haptoglobin mRNA (100%),
whereas 200 ng of total RNA of a carotid artery
1 day after ligation contained 38±46% (n=4) of
liver haptoglobin mRNA.
After a sustained blood flow increase (an increase
of about 10 times) as well as after a sustained
blood flow decrease (a decrease of about 0.5
times), haptoglobin mRNA was found in the
rabbit arterial wall. Both increased and decreased
blood flows in the right carotid artery were
accompanied by increased blood flow in the left
carotid artery. Without an operation on the left
carotid artery, blood flow increased to
compensate for the diminished blood flow to the
brain on the right side20. No blood flow changes
occurred in the untreated left femoral artery,
which served as a control.
One day after the blood flow increase,
haptoglobin mRNA expression was highest
(figure 2B, C). In the right femoral artery,
haptoglobin mRNA levels increased more then
100 times (p<0.0001) compared with it’s
contralateral control artery (figure 2E, G). The
haptoglobin mRNA levels in the right and left
carotid artery were also increased more then 100
times (p=0.05 and p=0.03, respectively)
compared with the control left femoral artery
(figure 2E, G). Haptoglobin mRNA levels,
determined by quantitative PCR, were the same
in the control left femoral artery and a femoral
artery of an unmanipulated animal (results not
shown).
To determine haptoglobin protein levels after a
sustained blood flow increase, the same arteries
were also used for Western blot analysis with an
antibody directed against human haptoglobin
(figure 2F, H). This assay revealed an appro-
ximate sevenfold increase in haptoglobin protein
in the operated right femoral artery compared
with the contralateral control artery (p=0.09).
Increases in haptoglobin protein levels of about
fivefold were also observed in the right and left
carotid arteries compared with the control femoral
artery (p=0.03 and p=0.12, respectively).
Haptoglobin was also present in human primary
adventitial fibroblasts (figure 2D) and was
secreted into the medium.
Haptoglobin and cell migration
As cell migration is an essential process in arterial
restructuring, we used mice embryonic
fibroblasts to investigate a potential role of
haptoglobin in cell migration. The absence of
haptoglobin in haptoglobin knockout embryonic
fibroblasts (figure 3A) resulted in slower
migration (p=0.03) of the fibroblasts as
compared with wild type and heterozygous
embryonic fibroblasts (figure 3B). Furthermore,
incubation of embryonic fibroblasts with LPS
induced an increase in haptoglobin mRNA
expression in wild type and heterozygous fibro-
Figure 1. Localization of haptoglobin mRNA in rabbit adventitial
fibroblasts.
A-B) In situ hybridization of rabbit carotid artery sections using an anti-
sense cRNA probe against rabbit haptoglobin mRNA (A) and a sense
control cRNA probe (B). Scale bar=125 µm. C) Detail of the indicated
area in A using an antisense cRNA probe against haptoglobin mRNA.
Scale bar=50 µm. D) Detail of haptoglobin mRNA-producing cells in
adventitia (bottom layer) and media (top layer), shown by an antisense
cRNA probe. Scale bar=12.5 µm. E-F) In situ hybridization and
immunohistochemical double staining of rabbit carotid artery sections by
using an antisense cRNA probe against haptoglobin mRNA and an
antibody directed against vimentin. E) Black staining of haptoglobin
mRNA. F) At another depth of field, the more prominent red vimentin
staining. Arrows indicate cells stained for haptoglobin mRNA (E) and
vimentin (F) in the adventitial layer. Scale bar=12.5 µm.
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Figure 2. Tissue expression of haptoglobin in rabbit and human cells
A) Tissue expression of haptoglobin mRNA in different rabbit tissues. Northern blot analysis of 20 µg of total RNA per lane. Lanes: 1 aorta, 2 adrenal
gland, 3 cerebellum, 4 frontal cortex, 5 heart, 6 hypothalamus, 7 mesenteric artery, 8 liver, 9 lung, 10 spleen, 11 neural retina, 12 kidney, 13 ovary, 14
renal artery and 15 thyroid gland; 10 µg of total RNA of buffy coat fraction in lane 16, carotid artery after 2 days of sustained flow changes in lane
17 and erythrocyte fraction in lane 18. The position of the 18S band is indicated. In right carotid (RC) and right femoral (RF) arteries, blood flow
changes were created surgically. In the left carotid (LC) artery, blood flow increased to compensate for the diminished blood flow to the brain on
the right side (20). No blood flow changes occurred in the untreated left femoral (LF) artery which served as a control. Typical results of Northern
blot analysis (10 µg/lane) are presented in B, C and E and of Western blot analysis (8 µg/lane) in F. B) Haptoglobin mRNA expression in rabbit arteries
after 1, 2 and 7 days of sustained blood flow decrease obtained by partial ligation. C) Haptoglobin mRNA expression in rabbit arteries after 1, 2 and
7 days of sustained blood flow increase obtained by arterio-venous shunting. D) Western blot of cell lysate (8 µg/lane) and medium (10 µg/lane)from
human primary adventitial fibroblasts stimulated for 24 h with 10 ng/ml of LPS. E) Haptoglobin mRNA expression in rabbit arteries 1 day after blood
flow increase. F) Left panel: haptoglobin protein expresion in rabbit arteries 1 day after blood flow increase. Right panel: denaturation of the right
carotid haptoglobin complex after 1 min at 100 °C (1), 3 min at 100 °C (3) and 5 min at 100 °C (5). Haptoglobin α− and β−subunits are indicated. G)
Relative haptoglobin mRNA levels in arteries of four rabbits determined by using Northern blot analysis (10 µg/lane). OD, optical density (arbritary
units). H) Relative haptoglobin protein levels in arteries of four rabbits  determined by using Western blot analysis (8 µg/lane). Protein was
extracted from the same arteries as used for G. The asterisk indicates statistical significance (P<0.05).
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blasts (figure 3A). As expected, no expression
was found in haptoglobin knockout cells.
Concomitant with the increase in haptoglobin
production, LPS treatment also increased the
number of migrating wild type and heterozygous
cells 1.5-2 times (p=0.02). The haptoglobin
knockout cells, in contrast, showed no increase
in the number of migrating cells (figure 3B).
Because haptoglobin is secreted, we reasoned
that medium from wild type fibroblasts might
rescue migration of the knockout cells. A
migration assay was performed with haptoglobin
knockout cells and wild type cells (figure 3C).
Again, incubation with LPS stimulated migration
of only the wild type cells, but the number of
migrating knockout cells increased (p=0.03) after
incubation in medium from wild type cells.
Unilateral common carotid ligation in wild
type and haptoglobin knockout mice
A murine carotid ligation model18 was used to
investigate whether arterial restructuring was
affected in haptoglobin knockout mice. Carotid
arteries were obtained at 5, 8 and 20 days after
cessation of blood flow.
At 5 days, morphometry showed no differences
in intimal, medial and adventitial cross-sectional
areas between wild type and haptoglobin
knockout mice (figure 4A). Hematoxylin-eosin
staining (figure 4B), however, showed that
morphological changes occurred in all three
layers in both groups as described earlier18. In
short, intimal lesions were detached from the
underlying internal elastic lamina (IEL), thereby
forming spaces filled with red blood cells,
leukocytes and macrophages. In the media, the
SMC structure disappeared and inflammatory
cell infiltration was observed. The latter occurred
also in the adventitia. At 8 days, morphometry
showed that the intimal and adventitial areas of
the carotid arteries of the knockout mice were
enlarged (figure 4A) compared with those of the
wild type mice. Arteries from the haptoglobin
knockout mice still had a detached intimal area,
abnormal SMC structure in the media and
infiltration of inflammatory cells in all three
arterial layers. The wild type mice, in contrast,
showed almost no intima hyperplasia and medial
SMC morphology appeared normal18. Throug-
hout the arterial wall, no inflammatory cells were
found.
At 20 days, morphometry and hematoxylin-eosin
staining (figure 4A, B) showed no differences
between the carotid arteries of the haptoglobin
knockout mice and the wild type mice. The artery
contralateral to the ligated artery showed no
neointima formation and no morphometric
differences between wild type and haptoglobin
knockout mouse (results not shown). Elastin von
Gieson staining showed that the internal and
Figure 3. Haptoglobin and cell migration
A-B) Haptoglobin expression and cell migration of murine primary
fibroblasts cell lines. A) Northern blot analysis of RNA (approximately
10 µg /lane) from six mice embryonic primary fibroblasts cell lines with
different haptoglobin genotypes (+/+ = wild type, +/- = heterozygous,
-/- = knock out). Top panels: Haptoglobin mRNA expression in primary
fibroblasts of six different embryos without LPS (left lane) or with 10 ng/
ml LPS (right lane). Bottom panels: 18S ribosomal bands of lanes in top
panels. B) Migration assay with primary fibroblasts of the same embryo’s
as used in A. Approximately 2x104 cells were used per chamber with
10 ng/ml LPS (black bars) or without LPS (white bars), without
chemoattractant. C) Cell migration of haptoglobin -/- fibroblasts.
Haptoglobin -/- fibroblasts from two embryos were incubated during
the migration assay without LPS (white bars), with 10 ng/ml LPS (black
bars), with 10 ng/ml LPS and medium from haptoglobin -/- fibroblasts
incubated 16 h with 10 ng/ml LPS (grey bars) or with 10 ng/ml LPS and
medium from haptoglobin +/+ fibroblasts incubated 16h with 10 ng/ml
LPS (striped bars). Haptoglobin +/+ fibroblasts were used as a positive
control.
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Figure 5. Haptoglobin and in vitro collagen breakdown
A-B) Western blot analysis of human arterial SMC (ATCC: CRL 1999)
culture medium after 24 h of incubation with various concentrations of
human haptoglobin protein (Biogenesis) using an antibody directed against
human collagen. A) Western blot analysis of cell culture medium containing
1% FCS (FCS), 1% FCS plus 10-6 M haptoglobin (10-6) or 1% FCS plus
10-8 M haptoglobin (10-8). B) Western blot analysis of cell culture medium
containing 1% FCS (FCS), 1% serum from wild type C57BL/6J mice (+/
+), 1% mouse serum from haptoglobin knockout C57BL/6J mice (-/-) or
1% serum from haptoglobin knockout mice plus 10-10 M haptoglobin
(10-10), 10-8 M haptoglobin (10-8) or 10-7 M haptoglobin (10-7). Top panel:
short exposure of the procollagen band (120 kDa) in the different media.
Bottom panel: longer exposure of the smaller collagen product (80 kDa)
using the same blot as in the top panel. C) Relative inhibition (in %) of
MMP-2 (left panel) and MMP-9 (right panel) activity with 10-5, 10-6, 10-
7 or 10-8 M human haptoglobin compared with 10-5 M BSA. Asterisk
indicates statistical significance (P<0.05). D) Example of gelatinase activity
after spotting 1 µl of Brij solution containing 1, 2 or 5 ng of MMP-2 or
MMP-9 protein on acrylamide gels. Gel 1 contained 8% acrylamide, 1
mg/ml gelatin, and F12 culture medium. Gel 2: same as gel 1 plus 10-6 M
collagen in F12 medium. Gel 3: same as gel 1 plus 10-6 M haptoglobin in
F12 medium. Gel 4: same as gel 1 plus 100 ng/ml marimastat, the MMP
inhibitor, in F12 medium. E) Zymographic determination of MMP-2 and
MMP-9 activity in medium (containing 0.1% FCS) from culture of mouse
embryonic fibroblasts heterozygous (+/-) or deficient (-/-) for haptoglobin.
Medium was incubated with the fibroblasts for 0, 1, 2 and 4 h (n=4).
external elastic laminae were intact in all arteries.
Haptoglobin mRNA and protein expression in
carotid arteries from wild type female BALB/c
mice after right carotid ligation (figure 4C) showed
an increase at 3 days in the right and left carotid
arteries. In the ligated right carotid artery,
haptoglobin mRNA was still increased at 5 days
after ligation. In this right carotid artery,
gelatinase activity was also increased at 3 days
(approximately 20 times, p=0.001).
Haptoglobin and collagen breakdown
Having demonstrated that haptoglobin is in-
volved in cell migration and arterial restructuring,
we studied whether haptoglobin could effect
collagen breakdown because this is an important
feature of both processes. The human arterial
SMC secretes procollagen, MMPs and only a
little haptoglobin compared with fibroblasts (re-
sults not shown). Newly synthesized
procollagen is proteolytically cleaved to mature
collagen and is built into the collagen fiber or
degraded by collagenases into two gelatin break-
down products, which are subsequently degraded
by gelatinases.
Human SMCs were cultured and the medium was
changed to a medium containing only 1% FBS
with different concentrations of human hapto-
globin. Western blotting revealed the presence of
procollagen proteins (130  kDa) and two main
smaller collagen proteins ( 80 kDa and 30 kDa)
(figure 5A). When 10-6 or 10-8 M haptoglobin
was added to the culture medium, procollagen
levels did not change, but the levels of the two
smaller collagen products increased. In addition,
we used serum from the haptoglobin knockout
mouse as a negative control and added haptoglobin
in increasing concentrations (figure 5B), which
produced an increase of the 80-kDa band when
the haptoglobin concentration increased.
On the basis of the primary collagenase cleavage
site, the molecular size of the collagen products
was almost equivalent to the calculated size of
the collagenase degradation (gelatin) products
of procollagen α1(I) and α2(I) (79.1 kDa and
26.4 kDa; 76.5 kDa and 23.6 kDa, respecti-
vely21). To assess whether the increase in
intermediate collagen breakdown products was
due to inhibition of gelatinase activity, we studied
the in vitro effect of haptoglobin on the gelati-
nases MMP-2 and MMP-9 in an activity assay
(figure 5C) and a gelatinase assay (figure 5D).
The MMP-2 and MMP–9 activity assays
revealed an inhibition in MMP-2 activity of
about 50% (p=0.004) for 10-5 M haptoglobin
and about 20% (p=0.04) for 10-6 M haptoglobin.
MMP-9 activity decreased by about 30%
(p=0.02) when 10-5 M haptoglobin was added.
Gelatin degradation by MMP-2 or MMP–9 was
studied in the presence of 10-6 M haptoglobin,
10-6 M collagen I or F12 medium. The MMP
inhibitor marimastat was used as a negative
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control. When haptoglobin was present, the
breakdown of gelatin was inhibited to 70% and
40% of the collagen control when 1 ng and 2 ng
of MMP-2 was added, respectively.
Zymography of medium from mouse embryonic
fibroblasts heterozygous (+/-) or deficient (-/-)
in haptoglobin (figure 5E) showed a stronger
increase in activity of MMP-2 (1.3-1.8 times)
and MMP-9 (3.4-13.8 times) when the medium
was incubated for 1, 2 and 4 h with +/- cells
compared with the -/- cells.
Discussion
Haptoglobin, an acute phase protein, is produced
mainly in the liver where it is released into the
plasma. It is generally considered to be important
for rapid hepatic clearance of hemoglobin from
plasma. Ahaptoglobinaemia, however, does not
cause impaired hemoglobin clearance22, a feature
also seen in haptoglobin knockout mice. In
contrast, the endocytosis of hemoglobin by
hemoglobin scavenger receptor CD163 in
macrophages can only occur via haptoglobin-
hemoglobin complexes23. During hemolysis,
however, haptoglobin knockout mice suffer
greater renal tissue damage and fail to repair
damaged renal tissue17, 24. This observation points
to a potential role for haptoglobin in tissue repair.
Other studies on haptoglobin indicate that it may
be involved in other extracellular matrix-related
processes. Malignant ovarian tumors25 and
abdominal aortic aneurysms26 are associated with
elevated haptoglobin plasma concentrations. In
vitro studies indicate a role for haptoglobin in
bone resorption27 and inflammation28-29.
Moreover, haptoglobin stimulates angiogenesis
both in vitro and in vivo30 and a haptoglobin-like
mRNA may be associated with localized
angiogenesis in human endometrium31.
Haptoglobin expression in the arterial wall
Expression of haptoglobin in arterial tissue has
not been reported before. In our studies reported
here, both a sustained increase and a decrease in
blood flow induced haptoglobin mRNA and
protein expression.
Altered shear stress and not wall tension appears
to be the main trigger for haptoglobin expression,
as no differences were found in mRNA levels in
arterial segments proximal (increased wall tension)
and distal (decreased wall tension) to the partial
ligation (results not shown). Haptoglobin ex-
pression in the nonoperated left carotid artery,
in which flow was increased because of collateral
flow, demonstrated that the blood flow change
and not the surgery initiated haptoglobin ex-
pression.
Haptoglobin mRNA expression was found in the
adventitia. Because no SMCs are present in the
adventitia, the colocalization with vimentin
showed that haptoglobin was produced in
adventitial fibroblasts and not macrophages.
Haptoglobin function
To investigate the role of haptoglobin in cell
migration, we incubated mouse fibroblasts with
LPS, which increased haptoglobin expression
and stimulated cell migration of wild type but
not of haptoglobin KO fibroblasts. Moreover,
medium from wild type fibroblasts increased
migration of knockout cells after LPS stimu-
lation, which demonstrates that haptoglobin is
involved in cell migration.
By using carotid ligation in haptoglobin knock-
out mice, cellular rearrangement and migration
was delayed, resulting in delayed repair of the
arterial wall and a prolonged inflammatory
response, in accordance with the time course of
carotid haptoglobin expression in wild type mice.
Haptoglobin expression was the highest in the
ligated right carotid artery, which showed a strong
inflammatory response at 5 days, but the left
carotid artery, which did not have an inflam-
matory response, also showed increased hapto-
globin expression. Thus, haptoglobin, because
of its involvement in cell migration and arterial
repair, probably also has an anti-inflammatory
function.
No morphological changes in the nonligated left
carotid artery were found in wild type and
haptoglobin knockout mice. This result does not
exclude the possibility that haptoglobin is
involved in structural arterial dilation but pro-
bably points to a backup mechanism for this
important physiological process.
Intimal hyperplasia was minimal in wild type
BALB/c mouse at 20 days. This finding may be
due to an earlier time-point used here (20 days in
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this study versus 28 days in the Lindner model)
and another mouse strain (BALB/c versus FVB)
with less intimal formation32. Gelatinase activity
was increased when haptoglobin expression was
highest, indicating that there is an association
between haptoglobin expression and gelatinase
activity in this mouse ligation model.
Appreciating the essential role of collagen in
blood flow-induced arterial remodeling and cell
migration, together with the association of
haptoglobin and extracellular matrix-related
processes, we hypothesized that haptoglobin is
involved in collagen turnover. In vitro, arterial
SMCs showed an increased production of the
80- and 30-kDa gelatin products when
haptoglobin was added to the incubation
medium. As no changes in procollagens were
found, we presumed that haptoglobin inhibits
gelatinases such as MMP-2 and MMP–9, which
were the major gelatinases in the SMC culture
medium (results not shown). An in vitro
gelatinase assay and a MMP-2 and MMP-9
activity assay both confirmed this assumption
by showing a decrease in MMP-2 and MMP –9
activity when haptoglobin was added. The
increase in MMP-2 and MMP–9 activity in
medium of heterozygous embryonic fibroblasts
is probably due to a feedback loop. The increase
in MMP-9 activity is higher than the increase in
MMP-2 activity. This result is probably due to
a more rapid response of MMP-9 than MMP-2
in the feedback loop and agrees with the early
response of MMP-9 activity compared with
MMP-2 activity in a murine carotis flow
cessation model33. To get the same amount of
gelatin breakdown, more MMPs are needed when
haptoglobin is present. Because haptoglobin is
separated from the MMPs in the zymogram, this
will result in an increase in gelatinase activity.
This result agrees with zymographic results with
pig arteries treated with or without the broad-
spectrum MMP inhibitor marimastat, showing
an increase in MMP-2 and MMP-9 activity after
MMP inhibition (unpublished data). However,
a modified MMP activity assay showed that there
was indeed less MMP activity in the same
MMP-inhibited arteries12. The increase in
MMP-2 and MMP–9 activity in medium of
haptoglobin-producing embryonic fibroblasts
confirms again the relationship between
haptoglobin and gelatinase activity but also shows
that regulation of gelatinase activity by
haptoglobin is complicated and needs further
investigation.
These results point to a new concept in which
haptoglobin-induced accumulation of gelatin
serves as a temporary matrix for cell migration,
analogous to the temporary fibrin matrix in
angiogenesis34. This hypothesis is in accordance
with the finding that inhibition of collagenases
and gelatinases, via either a recombinant tissue
inhibitor of metalloproteinases or a nonspecific
pharmaceutical MMP inhibitor, hinders angioge-
nesis35-37, which we attribute to the prevention
of gelatin formation by collagenases. Haptoglobin,
in contrast, stimulates angiogenesis30 which we
attribute to inhibition of gelatinases without
affecting collagenases. Our hypothesis may also
explain why the increase of the MMP-9/TIMP
balance failed to correlate with the migratory or
invasive capacity of endothelial cells in vitro38
because migration is also likely to depend on,
besides on the MMP-9/TIMP balance, tempo-
rary matrix formation.
The amount and role of liver-derived plasma
haptoglobin protein compared with artery-
derived haptoglobin in the arterial wall is still
unclear, as discrimination between haptoglobin
produced by different tissues is not possible.
High local arterial concentrations might be possi-
ble only when haptoglobin is produced at the
site where it is needed. Another possibility is
that arterial haptoglobin has other posttransla-
tional modifications, such as glycosylation,
compared with liver haptoglobin, resulting in
another function or activity as shown for MD-2
and Toll-like receptor signaling39.
In summary, our results demonstrate for the first
time the expression of haptoglobin in adventitial
fibroblasts of rabbit arteries after sustained
changes in blood flow. Cell culture and in vitro
assays showed that haptoglobin inhibited the
breakdown of gelatin and promoted fibroblast
cell migration. In vivo studies showed that
arterial restructuring was delayed in haptoglobin
knockout mice. We conclude that haptoglobin is
involved in arterial restructuring by facilitating
cell migration, probably via accumulation of a
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temporary gelatin matrix. Promotion of cell
migration by haptoglobin may be involved in
other vascular and nonvascular processes such
as angiogenesis, tissue repair, atherogenesis and
tumor cell invasion.
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Nitric oxide synthesis is involved in arterial haptoglobin expression
after sustained flow changes.
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The acute phase protein haptoglobin is highly expressed in arteries after sustained flow changes
and involved in cell migration and arterial restructuring. In the liver, haptoglobin expression is
mainly regulated by interleukin-6 (IL-6). In the artery, shear stress and NO influence IL-6
expression. In the present study, we demonstrate that NO synthesis is involved in the regulation
of arterial haptoglobin expression after sustained flow changes. Decreased haptoglobin
expression after NO-inhibition coincided with decreased IL-6 levels. However, IL-6 knockout
mice had normal arterial haptoglobin expression levels after sustained flow changes suggesting
that other mediators may provide compensatory mechanisms for the regulation of arterial
haptoglobin expression.
Introduction
Chronic changes in blood flow induce structural
remodeling of the arterial wall to normalize shear
stress1. Structural remodeling is an important
determinant of luminal narrowing after balloon
angioplasty and in de novo atherosclerosis.
Previously, we demonstrated that arterial
expression of the acute phase protein haptoglobin
is increased during arterial remodeling after
sustained flow changes and plays an important
role in cell migration and arterial restructuring2.
However, the regulatory pathways involved in
arterial haptoglobin expression are unknown.
Liver haptoglobin expression is thought to be
mediated through interleukin-6 (IL-6), rather
than other inflammatory cytokines like
glucocorticoids or TNFα. This is supported by
point mutations in IL-6 responsive elements in
the haptoglobin promoter region, resulting in
lower serum haptoglobin levels3-4. Arterial IL-6
expression has been demonstrated in endothelial
and smooth muscle cells during atherosclerosis5-
6, pointing to a regulatory role in arterial haptoglo-
bin expression.
IL-6 expression in endothelial cells can be regu-
lated by shear stress7 and nitric oxide (NO)8. NO
is an important mediator of arterial remodeling
as is demonstrated by studies using either NO
synthase (NOS) inhibitors9 or endothelial NOS
(eNOS)10 and inducible NOS (iNOS)11 knockout
mice. NO mediates different processes that lead
to arterial remodeling which involves the modu-
lation of metalloproteinase (MMP) expression
and activity12 and cell migration13. Previous
studies have shown that MMP inhibition can
prevent constrictive remodeling and subsequent
luminal narrowing14-17.
We hypothesized that NO production after
arterial flow changes regulates arterial expression
of haptoglobin, a gelatinase inhibitor, through
IL-6 expression. In this study, we show that NO
synthesis is involved in the regulation of arterial
haptoglobin expression after sustained flow
changes and suggest that this NO-haptoglobin
pathway is an important cellular mediator
between sustained flow changes and arterial
restructuring.
Material and methods
Animal models
The investigation conforms with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996).
Rabbits: In 14 New Zealand White rabbits, the right carotid artery was
completely ligated which also resulted in flow increase in the contralateral
left carotid artery. Rabbits received either 1.5 g/liter L-NAME in the
drinking water, starting 5 days before intervention (L-NAME treated
group, n=7) or normal water (control group, n=7). The carotid arteries
of 6 additional unoperated rabbits were used to obtain baseline expression
levels. The rabbits were anaesthetized by intramuscular injection of
methadone (0.15 ml) and ventraquil (0.15 ml) followed by intravenous
injection of etomidate (1mg/kg) and ventilated with N
2
O:O
2
 and 0.6%
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Halothane. Animals were sacrificed 1 day after operation and the
carotid, femoral and iliac arteries were removed. The arteries were
snap-frozen in liquid nitrogen and stored at -80°C for RNA and protein
extraction.
Mice: The IL-6 KO mice have been backcrossed into the wild type B6/
129 background for at least 15 generations at the time of the experiments.
Male wild type and IL-6 knockout mice (n=30) were anaesthetized
using 0.05 ml/10 g body weight of a cocktail (1 part Hypnorm, 1 part
Midazolam, 2 parts distilled water). The right common carotid artery
was ligated as described by Kumar and Lindner18. Animals were
sacrificed at 0 days (n=5/group) and 3 days (n=10/group) after operation
and the left and right carotid arteries were removed. The arteries were
snap-frozen in liquid nitrogen and stored at -80°C for RNA and protein
extraction.
RNA extraction
The frozen tissue samples were grinded in liquid nitrogen, using a pestle
and mortar. RNA was extracted using 1 ml Tri-pureTM Isolation Reagent
(Boehringer Mannheim) according to manufacturers protocol.
Northern blotting
Ten µg of RNA was separated on a 1.2% formaldehyde-agarose gel.
After capillary blotting to Hybond-N membrane (Amersham), the
membrane was baked for 2 hours at 80°C. Probes were prepared using
the random primed DNA labeling kit (Boehringer Mannheim). Hybridi-
zation occurred for 1 hour at 65°C in Easy-Hyb hybridization solution
(Stratagene) followed by 10 minutes washing in 0.1x standard saline
citrate (SSC), 0.1% sodium dodecyl sulfate (SDS) at 65°C. Bands were
visualized using Biomax MS films (Kodak).
Quantitative real-time PCR
Reverse transcription was carried out with 500 ng total RNA using
superscript II (Life) according to manufacturers protocol. To confirm
the identity of the amplified cDNA products, PCR products were ligated
into the pGEM-T Easy Vector (Promega) and sequenced using the T7
sequenase version 2.0 DNA sequencing kit (Amersham).
PCR amplification was performed using the I-cycler iGTM Real Time
PCR (Biorad). Each reaction contained 14 µl cDNA, 200 µM dNTP, 1x
reaction buffer (Gibco-BRL) containing 1:80.0000 Cybergreen (Biorad),
2.5 U Taq DNA polymerase (Gibco-BRL) and 1 µM of each primer.
Quantities were determined by comparison with known quantities of the
cloned PCR product representing the target mRNA. Data were corrected
for the amount of 18S mRNA that was used as an internal standard.
The following oligonucleotides were used as primers: rabbit haptoglobin
(forward 5’-GAAGCAGTGGGTGAACAAGG-3’, reverse 5’-TGAC
AAGATTGTGGCGGGAG-3’), rabbit interleukin-6 (forward primer 5’-
ACCACGATCCACTTCATCC-3’, reverse primer 5’-TGTCCTAACG
CTCATCTTC-3’), rabbit 18s (forward primer 5’-TCAACACGGGAAA
CCTCAC-3’, reverse primer 5’-ACAAATCGCTCCAGCAAC-3’),
mouse haptoglobin (forward 5’-AAAAACCTCTTCCTGAACCAC-3’,
reverse 5’-AACGACCTTCTCAATCTCCAC-3’), mouse 18s (forward
5’-TCAACACGGGAAACCTCAC-3’, reverse 5’-ACCAGACAAATC
GCTCCAC-3’).
Statistics
Data are presented as mean±sem. Statistical analysis was performed using
the Mann-Whitney U test. P<0.05 was considered as statistically
significant.
Results
To investigate the role of NO in the regulation
of arterial haptoglobin expression after flow
changes in rabbit carotid arteries, NO synthesis
was inhibited using the nonspecific NOS
inhibitor L-NAME. Northern blot analysis
showed that after flow changes, haptoglobin
mRNA levels increased more in carotid arteries
of control rabbits compared to the carotid arteries
of L-NAME treated rabbits, 1 day after flow
changes (figure 1A).
Quantitative real-time PCR was used to quantify
the relative amounts of haptoglobin mRNA
levels in the carotid arteries of unoperated, control
and L-NAME treated rabbits. In control rabbits,
both a flow increase and flow decrease in the
carotid artery resulted in a significant increase of
arterial haptoglobin mRNA expression compared
to baseline values (30-fold, p=0.005; figure 1B).
In L-NAME treated rabbits, a significant increase
in haptoglobin mRNA levels was observed com-
pared to baseline values (12-fold, p=0.005).
Figure 1. Arterial haptoglobin mRNA expression in rabbit carotid
arteries after L-NAME treatment, 1 day after sustained flow
changes
A) Northern blot hybridization showing haptoglobin mRNA expression
in L-NAME treated and control rabbits, 1 day after flow changes.
LF=unoperated left femoral artery; LC=left carotid artery; RC=right
carotid artery. B) Haptoglobin mRNA expression in carotid arteries after
sustained flow changes. C) Haptoglobin mRNA expression in unoperated
femoral and iliac arteries. Haptoglobin mRNA is presented as the amount
of plasmid containing the haptoglobin PCR product to which it correlates
in the dilution series of this plasmid used in the quantitative real-time
PCR. n=7 rabbits/group, * p<0.05; black bar=baseline values; grey
bar=control rabbits; white bar=L-NAME treated rabbits.
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Absolute haptoglobin mRNA levels, however,
were significantly decreased in the carotid arteries
of L-NAME treated rabbits compared to control
rabbits (33%, p=0.04; figure 1B). Basal
haptoglobin mRNA expression in unoperated
femoral and iliac arteries was not affected by L-
NAME treatment (figure 1C).
IL-6 is thought to be the major stimulator of
haptoglobin expression. Therefore, we inves-
tigated if IL-6 expression decreased after L-
NAME treatment. One day after flow changes,
IL-6 mRNA levels were significantly increased
compared to baseline values  in both the left and
right carotid artery of untreated rabbits (4-fold,
p=0.03; figure 2A). However, no increase in IL-
6 expression levels was observed in the carotid
arteries of L-NAME treated rabbits compared
to baseline values. L-NAME treatment had no
effect on basal expression levels of IL-6 mRNA
in unoperated femoral and iliac arteries (figure
2B).
To confirm the possible role of IL-6 in arterial
haptoglobin expression, haptoglobin expression
was measured in IL-6 knockout mice following
ligation of the right carotid artery (figure 3). In
wild type mice, haptoglobin mRNA levels
increased in the left and right carotid artery at 3
days after ligation of the right carotid artery (2-
fold, p=0.05). A similar increase in haptoglobin
mRNA expression was observed in IL-6 knock-
out mice 3 days after ligation of the carotid artery
(2-fold, p=0.05). Baseline haptoglobin expression
levels did not differ between wild type and IL-6
knockout mice (figure 3).
Discussion
Haptoglobin expression is increased in arteries
after sustained flow changes and involved in cell
migration and arterial restructuring2. The arterial
response to normalize wall shear stress after
blood flow changes depends on a functional
vascular endothelium19 that releases NO as a
mediator in the arterial remodeling process. In
the present study, we used the arterial ligation
model to investigate if NO induces arterial
haptoglobin expression after flow changes.
Inhibition of NO after flow changes using the
non-specific NOS inhibitor L-NAME partly
inhibited arterial haptoglobin expression. This
shows that a NO-dependent pathway is involved
in the regulation of arterial haptoglobin expression
after flow changes. There are at least two isoforms
of NOS expressed in the vascular system after
Figure 2. Interleukin-6 mRNA expression in rabbit carotid arteries
after L-NAME treatment, 1 day after sustained flow changes
 IL-6 mRNA is presented as the amount of plasmid containing the IL-6
PCR product to which it correlates in the dilution series of this plasmid
used in the quantitative real-time PCR. A) IL-6 mRNA expression in
carotid arteries after sustained flow changes. B) IL-6 mRNA expression
in unoperated femoral and iliac arteries. n=7 rabbits/group, * p=0.04;
LC=left carotid artery; RC=ligated right carotid artery; black bar=baseline
values; grey bar=control rabbits; white bar=L-NAME treated rabbits.
Figure 3. Haptoglobin mRNA expression in carotid arteries in IL-
6 knockout mice after sustained flow changes
Haptoglobin mRNA is presented as the amount of plasmid containing the
haptoglobin PCR product to which it correlates in the dilution series of
this plasmid used in the quantitative real-time PCR. n=8-10 arteries/group,
* p=0.05; black bar=carotid arteries, 0 days; grey bar=left carotid artery
3 days after ligation; white bar=ligated right carotid arteries, 3 days after
ligation.
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injury or flow changes20-22. There are, however,
differences in function between those isoforms.
NO derived from eNOS inhibits neointimal
formation whereas NO derived from iNOS
promotes neointimal formation. Moreover,
constrictive remodeling is impaired in eNOS
knockout mice whereas iNOS knockout mice
display more constrictive remodeling compared
to wild type mice10-11, 23. Unfortunately, the use
of L-NAME did not allow for identification of
the NOS isoform that is involved in the regulation
of arterial haptoglobin expression.
There are no reports demonstrating a direct effect
of NO or shear stress on haptoglobin expression.
However, some of the genes which are regulated
by NO appear to depend on the presence of
diffusible intermediates like cytokines24. IL-6
expression is an important regulator of
haptoglobin expression and expressed in both
endothelial7-8 and smooth muscle cells5-6 during
atherosclerosis. Moreover, IL-6 expression can
be regulated by NO and shear stress7-8, making
it a potential candidate to function as an inter-
mediate between increased NO synthesis and
arterial haptoglobin expression.
To investigate a possible regulatory role for IL-
6 in arterial haptoglobin expression, we
measured IL-6 expression levels after L-NAME
treatment. Although the L-NAME treated rabbits
still responded to flow changes with increased
haptoglobin mRNA levels, there was a significant
decrease in the absolute levels of haptoglobin
mRNA. This decrease in haptoglobin coincided
with baseline levels of IL-6, supporting a
regulatory role for IL-6 in arterial haptoglobin
expression.
IL-6 knockout mice were used to confirm if
arterial haptoglobin expression indeed is regu-
lated through IL-6 after sustained flow changes.
Surprisingly, the IL-6 knockout mice responded
normal to flow changes with increased hapto-
globin mRNA levels, demonstrating that IL-6 is
not the only regulator for the induction of hapto-
globin in the arterial wall. This is in accordance
with other studies showing that IL-6 is not the
sole regulator of haptoglobin expression25. For
instance, the induction of serum haptoglobin in
IL-6 and IL-6/TNF/LTalpha knockout mice is
only slightly reduced after stimulation with lipo-
polysaccharide (LPS)26. Apparently, multiple
signals exist which are able to induce haptoglobin
expression and can compensate for deficiencies
in regulators like IL-6.
In summary, this study demonstrates that NO
synthesis is involved in arterial expression of
haptoglobin after sustained flow changes, co-
inciding with increased IL-6 levels. Since the
increase in haptoglobin expression is normal in
IL-6 knockout mice after flow changes, we infer
that other unidentified mediators may provide
compensatory mechanisms for the regulation of
arterial haptoglobin expression after flow changes.
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The acute phase protein haptoglobin is locally expressed in arthritic
and oncological tissues.
M.B. Smeets1,2, J. Fontijn1, A. Kavelaars3, G. Pasterkamp1,2, D.P.V. de Kleijn1,2.
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Haptoglobin is an acute phase protein known to be highly expressed in the liver. Recently, we
showed increased local arterial haptoglobin expression after flow-induced arterial remodelling
and found that haptoglobin is involved in cell migration and arterial restructuring probably
through accumulation of a temporary gelatine matrix. Since cell migration and matrix turnover
are important features in the pathology of arthritis and cancer, we hypothesised that haptoglobin
is also expressed in arthritic and oncological tissues. In this study, we investigated local
haptoglobin expression in arthritic rats (n=12) using semi-quantitative PCR, western blotting
and studied haptoglobin mRNA localisation in human kidney tumours (n=3) using in situ
hybridisation. The arthritic rats demonstrated an increase of haptoglobin mRNA (2.5-fold,
p<0.001) and protein (2.6-fold, p<0.001) in the arthritic achilles tendon. Haptoglobin protein
was also increased in the arthritic ankle (2.6-fold, p<0.001) but not in the non-arthritic knee. In
human kidney tumours, tumour and stromal cells produced haptoglobin mRNA. This study
shows that the liver protein haptoglobin is, besides the artery, also expressed in arthritic and
Introduction
Haptoglobin is mainly produced in the liver but
expression can also be induced in various other
tissues1. Recently, we demonstrated that the acute
phase protein haptoglobin is a natural inhibitor
of collagen degradation and is locally expressed
in fibroblasts of the arterial wall. Haptoglobin
plays an important role in cell migration and
arterial restructuring2. Collagen turnover is an
important feature in many physiological pro-
cesses like growth and wound healing. Enhanced
collagen degradation is observed and often
causally related with severe tissue destruction
or malfunction as can be seen in the pathological
processes of arthritis3 and cancer4.
The importance of haptoglobin in cell migration
and extracellular matrix degradation suggests a
role for haptoglobin in arthritis and cancer. Both
disease processes are characterised by increased
cell migration and degradation of the extracellular
matrix. Invasion of arthritic fibroblast-like syno-
viocytes rapidly destroys a cartilage matrix5. In
cancer, the migration of cells plays a role in tumor
angiogenesis, progression and metastasis6.
Although sero-epidemiological studies reported
increased haptoglobin serum levels during
arthritis and carcinogenesis7-8,  local expression
of haptoglobin in arthritic and oncological tissues
has not been studied before. We hypothesised
that local expression of haptoglobin will increase
in arthritic and oncological tissues in which cell
migration and matrix remodelling are important
features.
In the present study, we investigated local ex-
pression of haptoglobin in arthritis and cancer
and describe that haptoglobin was locally
expressed in arthritic and oncological tissues in
which extracellular matrix turnover and cell
migration are predominant features.
Material and methods
Tissue material
Arthritic rats: In 6-8 weeks old inbred male Lewis rats (n=6), arthritis
was induced by one single intradermal injection of 5 µg/ml heat-killed
Mycobacterium tuberculosis (strain H37Ra, Difco) in Freund’s incomplete
adjuvant (Difco) in the base of the tail9; 6 additional rats were used as
control. The rats were terminated after 6 weeks. The arthritic ankle and
Achilles tendon as well as the unaffected knee were removed, snap-
oncological tissues recognised for enhanced cell migration and matrix turnover.
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Tween (PBST). Detection occurred using ECL (NEN Life Science
products) and exposure to X-Omat Blue XB-1 films (Kodak).
Statistics
Data are presented as mean±sem. The arthritic rats were analysed
using the Mann-Whitney U test. P values <0.05 were considered as
statistically significant.
Results
Local haptoglobin expression in arthritic
tissue.
Haptoglobin expression in the arthritic rats
(n=12) was investigated using the affected ankle
and achilles tendon and the unaffected knee.
Haptoglobin mRNA expression was 2.5-fold
increased in the achilles tendon in arthritic rats
(p<0.001) (Figure 1A). Haptoglobin mRNA
levels in the ankle revealed large fluctuations
within the two groups but showed no significant
differences between the arthritic and control rats
(p=0.51) (figure 1A). No significant difference
was found in haptoglobin mRNA levels in the
frozen in liquid nitrogen and stored at –80°C for RNA and protein
extraction.
All investigations conformed to the Guide for the Care and Use of
Laboratory Animals (NIH publication No.85-23, 1985) and were
approved by the ethical committee on animal experiments of the
University Medical Center Utrecht.
Human kidney tumours: Surgical specimens from human Grawitz kidney
tumours were immediately snap-frozen in liquid nitrogen and stored at
-80°C for in situ hybridisation (n=3).
RNA and protein extraction
The frozen tissue samples were grinded in liquid nitrogen, using a pestle
and mortar. RNA and protein were extracted using 1 ml Tri-pureTM
Isolation Reagent (Boehringer Mannheim) according to manufacturer’s
protocol.
Semi-quantitative RT-PCR
Specific sets of primers were constructed using software at CMBI
(Nijmegen). Reverse transcription was carried out with 500 ng total
RNA using superscript II (Life) according to manufacturers protocol.
To confirm the identity of the amplified cDNA products, PCR products
were ligated into the pGEM-T Easy Vector (Promega) and sequenced
using the T7 sequenase version 2.0 DNA sequencing kit (Amersham).
PCR amplification on arthritic rats was performed using 11 µl cDNA,
200 µM dNTP, 1x reaction buffer (BRL), 2.5 U Taq DNA polymerase
(BRL) and 1 µM of each primer. The reaction was run on 8%
polyacrylamide gels, stained with ethidium bromide and analysed using
the Gel-Doc 1000 system. Control experiments were performed to
determine the range of PCR cycles over which amplification efficiency
remained constant and to demonstrate that the amount of PCR product
was directly proportional to the amount of input cDNA. PCR amplification
on total RNA which had not been reversed transcribed showed that no
genomic DNA was present (data not shown). Data were corrected for
the amount of β-actin mRNA, which was used as an internal standard.
The following oligonucleotides were used as primers: rat haptoglobin
(forward primer 5’-TGATCAAGCTCAAACAGAAAGTG-3’, reverse
primer 5’-ATAGCAAGTGTCTTCCTCATACTT-3’), rat β-actin
(forward primer 5’-AAGGAACAACCCAGCATCC-3’, reverse primer
5’-AGAGCCACCAATCCACACA-3’).
In situ hybridisation
Human haptoglobin cDNA in pGEM-T Easy Vector was linearised
and used as template to obtain Digoxigenin (DIG, Roche) labelled RNA
probes according to manufacturers protocol. Tissue segments were cut
into 8 µm sections and transferred to Superfrost plus slides (Menzel
Glazer) and stored at –80°C until use.
After defrosting, sections were treated with 0.2 M HCl for 20 min at RT,
washed three times with PBS for 5 min and treated with proteinase K
(Roche 10 µg/ml) for 10-15 minutes at 37°C in PBS. The sections were
washed with PBS and fixed at RT for 5 minutes in 4% paraformaldehyde
and treated twice for 5 min with acetic anhydride in triethylacetate (TEA,
185 µl acetyl anhydride in 0.1 M TEA). Sections were subsequently
washed twice in 2xSSC for 5 min at RT, followed by 5 min in 2XSSC/
50%formamide at 37°C.
For prehybridisation, 100 µl hybridisation mix (50% formamide, 1mg/
ml tRNA, 1x Denhardts, 10% dextrane sulfate, 4xSSC) was added to the
slide and incubated for 1 hour at 46°C. After o/
n
 hybridisation with a DIG
(1 µl)-labeled probe at 46°C, sections were washed with 0.1xSSC at
45°C for 15 min, followed by RNase treatment (40 µg/ml RNase A,
1mM EDTA pH8.2, 2xSSC) for 15 min at RT and washed again with
0.1xSSC at 45°C for 15 min. Before detection with 1/500 sheep-α-DIG
AP (Boehringer), sections were rinsed with 2xSSC and 100 mM Tris
pH7.4-150 mM NaCl at RT. Detection with NCBI/NBT (Roche) was
performed according to manufacturer’s protocol.
Western blotting
Equal amounts of protein (5 µg/lane) were separated on a 10% SDS
polyacrylamide gel and blotted onto Hybond ECL (Amersham) in blotting
buffer (14.4 g/l Glycine, 3.03 g/l Tris, 20% methanol). The membrane
was blocked o/
n
 in PBS-0.1% Tween-5% non-fat dry milk (PBSTP). The
membrane was incubated for 1 hour at RT with 1/4000 goat-α-human
haptoglobin (ICN), followed by 1/1000 biotinylated rabbit-α-goat and
1/2000 streptavidine-horseradish peroxidasae. All incubation steps were
performed in PBSTP and subsequently washed 3 times in PBS-0.1%
Figure 1. Haptoglobin mRNA and protein expression in arthritic
rats
A) haptoglobin mRNA levels in control and arthritic rats, B) western
blot analysis of haptoglobin protein in ankle, tendon and knee (c=control
rat, a=arthritic rat), C) haptoglobin protein levels in control and arthritic
rats. n=9, * p<0.001, black bar=control rats, grey bar=arthritic rat.
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12. Recently, we have identified haptoglobin as
an essential factor for cell migration2. Hapto-
globin knockout cells demonstrated impaired
migration that could be restored by
supplementation of exogenous haptoglobin to the
cells. Although serum haptoglobin levels have
previously been associated with the progression
and outcome of arthritis and cancer7-8, local
haptoglobin synthesis has not been studied
before in these pathological tissues. As cell
migration is believed to be a tightly controlled
process that depends on matrix degradation in
the immediate surrounding of cells13, we inves-
tigated in the present study the local expression
of haptoglobin in arthritic and oncological tissues.
Previous studies have demonstrated increased
haptoglobin levels in the serum during arthritis7.
In arthritic rats, the affected ankle and Achilles
tendon showed significantly increased levels of
local haptoglobin expression. No differences
were found in the unaffected knee demonstrating
that increased haptoglobin protein levels in the
affected joints are the result of local haptoglobin
expression and not due to extravasation of
unaffected knee between arthritic and control rats.
Western blotting revealed that haptoglobin
protein expression was 2.6-fold increased in both
the arthritic ankle and the arthritic Achilles
tendon (p<0.001) from arthritic rats (figure 1B
+C). No differences in haptoglobin protein
expression were found in the unaffected knee.
Haptoglobin expression in oncological tissue.
In situ hybridisation on human Grawitz tumours
(n=3) demonstrated haptoglobin expression by
tumour cells located in invasive parts of the
tumour (figure 2A+C). Alternate sections
hybridised with a control sense probe showed
no staining (figure 2B). Interestingly, positive
staining was also found in surrounding stromal
tissue (figure 2D) by macrophages and
fibroblast-like cells (data not shown).
Discussion
Cell migration and collagen degradation are key
events in arthritis3, 10, tumour progression and
tumour metastasis4, 6. Enhanced degradation of
collagen is required for cell migration to occur11-
Figure 2. In situ hybridisation on human kidney tumours using an anti-sense probe against human haptoglobin mRNA
A) haptoglobin mRNA expression by invasive tumour cells (magnification=100x), B) in situ hybridisation using a sense probe (magnification=100x),
C) detail of the indicated area in A (magnification=400x) D) haptoglobin mRNA expression by surrounding stromal cells (magnification=200x). T=
tumour tissue, N=normal kidney tissue, bar=25 µm.
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haptoglobin from the serum.
Fibroblast-like synoviocytes of human arthritic
tissue migrate in vivo into cartilage matrix
resulting in a destructive pannus as is found in
human arthritic tissue5. These fibroblast-like
synoviocytes are the main producers of  the high
local levels of MMPs10, 14 that correlate with the
severity of the lesion and are mainly produced
in arthritic tissue10. We infer that local
haptoglobin expression facilitates cell migration
in the cartilage and may therefore play a role in
the progression of arthritis.
Haptoglobin mRNA was also locally expressed
in kidney tumour tissue. Cells staining positive
for haptoglobin mRNA were mainly found in the
invasive part of the tumour and in the
surrounding stroma. Haptoglobin protein levels
were not measured in the tumour samples due to
contamination with blood residues. The
localisation of haptoglobin correlated with the
earlier described expression pattern of MMP-2,
which is mainly synthesised by fibroblasts in the
stroma surrounding the tumours although the
active protein can also be found around tumour
cells15-16. Furthermore, MMP synthesis by
surrounding stromal cells is necessary for tumour
metastasis indicating the important role of
stromal-derived MMP activity17. Increased
expression of MMPs has been associated with
tumour invasion, metastasis and angiogenesis
and the controlled degradation of surrounding
stromal matrix appears to be essential for these
three processes15-16, 18. We suggest that hapto-
globin provides tumour cells with an additional
level of MMP-2 regulation besides the controlled
activation via MT1-MMP19-20 thereby facilitating
tumour cell invasion and metastasis.
Elevations in serum haptoglobin levels during
pathological processes have been demonstrated
by various sero-epidemiological studies.
However, local expression of haptoglobin in
pathological tissues has not been studied. There
are two possible explanations for the necessity
of increased local haptoglobin synthesis in
pathological processes, despite the normal
presence of haptoglobin in the serum. First,
increased local expression might be the only way
to achieve high local concentrations of haptoglo-
bin which are necessary for the inhibition of local
gelatinase activity. Second, local production of
haptoglobin might reflect the synthesis of a
functionally distinct protein, compared to
haptoglobin produced in the liver.
It is known for several proteins like eNOS or
Toll-like receptor-4 that changes in the amount
and nature of glycosylation can alter protein
function drastically21-22. Haptoglobin is a protein
with several posttranslational glycosylations on
the β-chains23 and alterations in the glycosylation
pattern of haptoglobin have been described
during the development and progression of
various pathological processes and even appear
to have prognostic values for some diseases24.
Increased local haptoglobin expression with
other glycosylation patterns might therefore
reflect an altered function compared to hapto-
globin produced in the liver.
A limitation of this study is that it is purely
descriptive and we can only speculate about the
exact function of haptoglobin in these tissues.
However, haptoglobin is locally produced in both
pathological tissues and is described to be
involved in cell migration and matrix degradation.
Since cell migration and matrix degradation are
important features in arthritis and cancer, this
suggests a local role for haptoglobin in these
processes and supports a role for haptoglobin in
the initial response to tissue injury. This is in
accordance with studies in haptoglobin knockout
mice that showed a delayed response to arterial2
or kidney injury25.
In summary, we have investigated local haptoglo-
bin expression in arthritis and cancer where cell
migration and matrix remodelling are important
features and describe an upregulation of local
haptoglobin expression in arthritic and oncolo-
gical tissues.
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Background: Haptoglobin is an acute phase glycoprotein that is highly expressed in the liver
and secreted into the serum. Recently, we observed arterial haptoglobin expression after
sustained flow changes and found that haptoglobin is a cell migration factor involved in arterial
restructuring. Although the function of extrahepatic haptoglobin expression is not yet
understood, local haptoglobin expression may provide the tissue with functionally different
haptoglobin due to posttranslational modifications. We hypothesized that haptoglobin
expression is increased during arterial restructuring after balloon dilation and compared
glycosylation patterns between arterial and liver haptoglobin. Methods and Results: Arterial
haptoglobin expression was studied in rabbits at 0, 2, 7, 14 and 28 days after balloon dilation
(n=36) using quantitative PCR, western blotting and in situ hybridization. After balloon dilation,
arterial haptoglobin mRNA levels were maximally increased at 7 days (5.7-fold, p=0.01), whereas
protein levels were maximal at 14 days (1.4-fold, p=0.01). Haptoglobin was only expressed in
the adventitia of balloon dilated arteries, which was confirmed in human atherosclerotic coronary
arteries. Liver haptoglobin expression remained constant after balloon dilation. Two-dimensional
gel electrophoresis and lectin affinity blotting were used to identify liver and arterial haptoglobin
glycoforms and revealed the expression of artery-specific haptoglobin glycoforms. Conclusions:
This study demonstrates that arterial haptoglobin expression is increased early after balloon
dilation whereas liver haptoglobin expression did not change. Furthermore, arterial haptoglobin
consists of an unique set of glycoforms compared to haptoglobin produced in the liver.
Introduction
Haptoglobin is an acute phase glycoprotein that
is mainly produced in the liver and secreted into
the serum1-2. There is, however, increasing evi-
dence that haptoglobin is also expressed in various
extrahepatic tissues like lung, kidney, skin and
heart3-4. Furthermore, extrahepatic haptoglobin
expression can be induced by lipopolysaccharide
(LPS)5.
Recently, we demonstrated that haptoglobin is
locally expressed in the arterial wall after
sustained flow changes. Haptoglobin was found
to play an important role during cell migration
and involved in flow-induced arterial restruc-
turing6. Arterial restructuring determines the
degree of lumen loss in pathological arterial
processes like restenosis7 and atherosclerosis8,
suggesting a role for haptoglobin in these pro-
cesses.
Although the function of extrahepatic
haptoglobin synthesis is not yet understood, local
haptoglobin synthesis may provide tissues with
a source of functionally or structurally different
haptoglobin. Tissue-specific glycosylation of
proteins has been demonstrated for many pro-
teins and it is known that glycosylation can
modify protein function or structure9. Serum
haptoglobin concentrations increase during
inflammation10 and tissue injury11 and are
accompanied by changes in haptoglobin
glycosylation that have been associated with
disease development and progression12. Thus,
increased extrahepatic synthesis and secretion of
differentially glycosylated haptoglobin might
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explain the observed variations in haptoglobin
glycosylation during various diseases.
In this study, we hypothesize that arterial
haptoglobin synthesis is increased after balloon
dilation and characterized by differentially
glycosylated arterial haptoglobin compared to
liver derived haptoglobin. We show that arterial
haptoglobin expression is increased in the
adventitial layer early after balloon dilation in
rabbits whereas haptoglobin liver expression
remains constant. Furthermore, we demonstrate
that arteries produce an unique set of haptoglobin
glycoforms that is distinctive from liver derived
haptoglobin.
Material and Methods
Tissue material
Rabbits Balloon dilation was performed in the femoral and iliac arteries
of 30 New Zealand white rabbits. The contra-lateral artery was used as a
control artery. Undilated femoral and iliac arteries from six additional
rabbits were used to determine haptoglobin baseline levels (=day 0). The
rabbits were anesthetized by intramuscular injection of methadone (0.15
ml) and vetranquil (0.15 ml) followed by intravenous injection of etomidate
(1mg/kg) and ventilated with N
2
O:O
2
 and 0.6% Halothane. A 3.0 mm
balloon was inflated 3x30 seconds with a pressure of 6-8 atmospheres.
Arterial diameters changes at the internal elastic lamina were determined
by measuring arterial lumen using angiography after balloon dilation and
at termination. Arterial diameter changes were corrected for intimal
hyperplasia thickness determined by histology cross-sectional analysis.
After 0, 2, 7, 14 and 28 days, the rabbits were sacrificed. A small segment
of the artery was fixated for 2 hours in 4% paraformaldehyde at room
temperature (RT), followed by over night (o/
n
) incubation in 15% sucrose
in PBS. After embedding in Tissue Tec (Sakura), the segment was stored
at -80°C. The remaining part of the artery was snap-frozen in liquid
nitrogen and stored at -80°C for RNA and protein extraction. Liver
samples were snap-frozen in liquid nitrogen and stored at -80°C for RNA
and protein extraction. Blood samples were collected at termination; serum
was isolated after centrifugation and stored at -80°C.
All investigations conformed to the Guide for the Care and Use of
Laboratory Animals (NIH publication No.85-23, 1985) and were approved
by the ethical committee on animal experiments of the University Medical
Center Utrecht.
Human coronary arteries Coronary arteries (left anterior descending,
left circumflex and right coronary arteries), removed directly after heart
transplantation, were used to perform in situ hybridization (n=3). The
arteries were fixated for 2 hours in 4% paraformaldehyde at RT, followed
by o/
n
 incubation in 15% sucrose in PBS. After embedding in Tissue Tec
(Sakura), the segment was stored at -80°C.
RNA and protein extraction
The frozen tissue samples were grinded in liquid nitrogen, using a pestle
and mortar. RNA and protein were extracted using 1 ml Tri-pureTM
Isolation Reagent (Boehringer Mannheim) according to manufacturers
protocol. Protein samples for 2D gel electrophoresis were isolated using
40 mmol/L Tris, pH7.5. Protein concentrations were determined using
the Bio-rad DC protein assay.
Real-time PCR
Reverse transcription was carried out with 500 ng total RNA using
superscript II (Life) according to manufacturers protocol. To confirm
the identity of the amplified cDNA products, PCR products were ligated
into the pGEMâ-T Easy Vector (Promega) and sequenced using the T7
sequenase version 2.0 DNA sequencing kit (Amersham).
PCR amplification was performed using the I-cycler iGTM Real Time
PCR (Bio-rad). Each reaction contained 14 µl cDNA, 200 µΜ dNTP, 1x
reaction buffer (BRL) containing 1:100.0000 Cybergreen (Bio-rad),
2.5 U Taq DNA polymerase (BRL) and 1 µΜ of each primer. Quantities
were determined by comparison with known quantities of the cloned
PCR products representing the target mRNAs. Data were corrected for
the amount of 18S or β-actin mRNA, which were used as internal
standards.
The following oligonucleotides were used as primers: rabbit haptoglobin
(forward primer 5’-GAAGCAGTGGGTGAACAAGG-3’, reverse primer
5’-TGACAAGATTGTGGCGGGAG-3’), rabbit 18s (forward primer 5’-
TCAACACGGGAAACCTCAC-3’, reverse primer 5’-ACAAATCGCTC
CAGCAAC-3’), human haptoglobin (forward primer 5’-TTCTACAC
CCTAACTACTCCCAGG-3’, reverse primer 5’-TAACCCACAC GCCC
TACTTC-3’), human β-actin (forward primer 5’-CTGTACGCCAAC
ACAGTG CT-3’, reverse primer 5’TCCACACAGAGTACTTGCGC-3’).
In situ hybridization
Human and rabbit haptoglobin cDNA in pGEM-T Easy Vector was
linearized and used as template to obtain digoxigenin (DIG, Roche) labeled
RNA probes according to manufacturer’s protocol. Tissue segments
were cut into 8 µm sections and transferred to Superfrost plus slides
(Menzel Glazer) and stored at –80°C until use.
After defrosting, sections were treated with 0.2 mol/L HCl for 20 min at
RT, washed three times with PBS for 5 min and treated with proteinase K
(Roche 10 µg/ml) for 10-15 minutes at 37°C in PBS. The sections were
washed with PBS and fixed at RT for 5 minutes in 4% paraformaldehyde
and treated twice for 5 min with acetic anhydride in triethylacetate (TEA,
185 µl acetyl anhydride in 0.1 mol/L TEA). Sections were subsequently
washed twice in 2xSSC for 5 min at RT, followed by 5 min in 2XSSC/50%
formamide at 37°C.
For prehybridization, 100 µl hybridization mix (50% formamide, 1mg/
ml tRNA, 1x Denhardts, 10% dextrane sulfate, 4xSSC) was added to the
slide and incubated for 1 hour at 46°C. After o/
n
 hybridization with a
DIG (1 µl)-labeled probe at 46°C, sections were washed with 0.1xSSC
at 45°C for 15 min, followed by RNAse treatment (40 µg/ml RNAse A,
1mmol/L EDTA pH8.2, 2xSSC) for 15 min at RT and washed again with
0.1xSSC at 45°C for 15 min. Before detection with 1/500 sheep-α-DIG
AP (Boehringer), sections were rinsed with 2xSSC and 100 mmol/L Tris
pH7.4+150 mmol/L NaCl at RT. Detection with NCBI/NBT (Roche)
was performed according to manufacturer’s protocol.
One- and two-dimensional gel electrophoresis
For one-dimensional gel electrophoresis, equal amounts of total protein
(5 µg/lane) were separated on a 10% sodium dodecyl sulfate poly-
acrylamide gel (SDS-PAGE) under reducing conditions.
For two-dimensional gel (2D gel) electrophoresis, equal amounts of
protein (100 µg for tissue samples, 1 µl for serum) were diluted to 125
µl with rehydration buffer (8 M urea, 2% CHAPS, 50 mM DTT, 0.2%
Bio-Lyte 3/10 ampholyte, 0.001% bromophenol blue; Bio-rad) and
used to rehydrate 7 cm IPG dry strips pH4-7 (Bio-rad) at 50 Volt for 12
hours at 20°C. The rehydrated strips were focussed by 2 hours ramping
to 4000 Volt, followed by an additional 20,000 Volthours. The strips
were placed for 10 minutes in equilibration solution (6 M urea, 375 mM
Tris-HCl pH8.8, 30% glycerol, 2% SDS; Bio-rad) containing 100 mM
DTT, followed by 10 minutes in equilibration buffer containing 135 mM
iodoacetamide. The equilibrated strips were run on a 12% SDS-PAGE.
Western blotting and lectin affinity blotting
Proteins were electrophoretically transferred onto Hybond ECL
(Amersham) and blocked o/
n
 at 4°C in block solution (PBS, 0.1% Tween,
5% non-fat dry milk). The membrane was incubated for 1 hour at RT
with goat-α-human haptoglobin (Sigma, 1/1000), biotinylated GNA (EY
laboratories, 1/1000) or biotinylated lotus tetragonolobus (Sigma, 1/1000),
followed by 1 hour incubation with biotinylated rabbit-α-goat (DAKO,
1/1000) and peroxidase labeled streptavidine (SBA, 1/1000). Detection
occurred using ECL (NEN Life Science products) and exposure to X-
Omat Blue XB-1 films (Kodak). As a negative control, the goat-α-
human haptoglobin antibody was substituted by normal goat serum or
blocked with 4 µg purified human serum haptoglobin (Sigma).
Statistics
Data are presented as ratio operated versus control artery or mean±sd.
Statistical analysis for the balloon dilated rabbits was performed using a
Wilcoxon matched pairs signed rank sum test. P values <0.05 were
considered as statistically significant.
Chapter5.pmd 12/3/02, 20:5653
Arteries express a novel haptoglobin glycoform
54
To measure haptoglobin mRNA and protein
expression, real-time PCR and western blotting
was performed. Haptoglobin mRNA expression
was significantly increased at 2, 7 and 14 days
(p<0.04) after balloon dilation with peak values
at 7 days (median=5.7-fold) (figure 1B). At 28
days, haptoglobin mRNA levels were returned
to baseline levels. Haptoglobin protein levels
were significantly increased in the balloon dilated
arteries with a maximum at 14 days after balloon
dilation (median=1.4-fold, p=0.01) (figure 1C).
The signal disappeared after blocking the primary
haptoglobin antibody with an excess of purified
haptoglobin or substitution with normal goat
serum (data not shown).
To identify the cells expressing haptoglobin, we
performed in situ hybridization. A strong staining
for haptoglobin mRNA in balloon dilated rabbit
arteries was observed in cells in the adventitial
layer (figure 2A); no staining was observed in
the media or neointima. The localization of
haptoglobin mRNA in rabbit arteries was
confirmed by in situ hybridization in human
atherosclerotic coronary arteries where haptoglo-
bin mRNA was mainly expressed in adventitial
cells although some positive cells were also found
in the media and plaque (figure 2C). Alternate
sections hybridized with a control sense probe
showed no staining (figure 2B+D).
Arterial versus liver haptoglobin expression
To investigate the relative importance of arterial
haptoglobin synthesis, haptoglobin mRNA and
protein levels were compared before and 2 days
after balloon dilation in liver and arterial tissue
samples. Haptoglobin mRNA and protein levels
increased significantly in the artery after balloon
dilation (figure 3A+B). However, liver
haptoglobin mRNA and protein levels remained
constant after balloon dilation (figure 3A+B).
The maximum levels of arterial haptoglobin
mRNA after balloon dilation were 345%
compared to control livers whereas arterial hapto-
globin protein increased to 209% of liver
haptoglobin.
Results
Haptoglobin expression after balloon dilation
The arterial response after balloon dilation is
depicted in figure 1A. At 2 days after balloon
dilation, the balloon dilated arteries were slightly
enlarged. Constrictive remodeling started at day
7 after balloon dilation and continued up to 28
days. Neointima formation was first found at 7
days after balloon dilation and progressively
continued up to 28 days. Since both arteries
reacted the same to balloon dilation, the data
from femoral and iliac arteries were pooled.
Figure 1. Haptoglobin mRNA and protein levels after balloon
dilation in rabbit femoral and iliac arteries
A) mean intimal hyperplasia (as % of total arterial diameter, white bars)
and the relative diameter change (as % of total arterial diameter, black
bars) in balloon dilated arteries between post-dilation and at termination,
B) ratio of haptoglobin mRNA levels between balloon dilated and control
arteries, and C) ratio of haptoglobin protein between balloon dilated and
control arteries. n=6-8 rabbits per time-point, * p=0.01, † p=0.04.
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Figure 2. Localization of arterial haptoglobin mRNA
A) in situ hybridization on balloon dilated artery, 7 days after balloon dilation using an anti-sense probe for rabbit haptoglobin mRNA, and B) using a
sense probe. C) in situ hybridization on human atherosclerotic coronary artery using an anti-sense probe for human haptoglobin mRNA, and D) using
a sense probe. IEL= internal elastic lamina, EEL=external elastic lamina, magnification=100x, bar=50 µm
Figure 3. Tissue expression levels of haptoglobin, before and 3
days after balloon dilation
A) Haptoglobin mRNA expression in liver and artery. Haptoglobin
mRNA is presented as the amount of plasmid containing the haptoglobin
PCR product to which it correlates in the dilution series of this plasmid
used in the quantitative real-time PCR. B) Haptoglobin protein expression
in liver and artery. OD= optical density (arbritary units). n=4, * p=0.03,
† p=0.02.
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were detected (figure 4D).
As haptoglobin is a glycoprotein, lectin affinity
blotting was used to determine differences in
haptoglobin glycosylation between liver and
arterial haptoglobin. The reactivity to the lectins
GNA and lotus tetragonolobus demonstrated that
terminal mannose and fucose residues were
present on arterial haptoglobin but not on liver
haptoglobin (figure 5). Serum samples also
reacted positive for the two lectins.
Discussion
Recently, we demonstrated that haptoglobin is a
novel cell migration factor and gelatinase-inhibitor
that is expressed in arteries after sustained flow
changes and involved in arterial restructuring6.
Furthermore, haptoglobin has been associated
with other extracellular matrix related processes
like angiogenesis13 and cancer14. Extracellular
matrix turnover and arterial restructuring are
important processes after balloon dilation. In the
present study, we investigated the local ex-
pression of haptoglobin after balloon dilation and
the presence of arterial haptoglobin glycoforms.
Haptoglobin expression in balloon dilated rabbit
arteries was increased within the first two weeks
after balloon dilation with peak values at 7 days
and correlated with the time period for increased
MMP expression and cell migration after arterial
injury15-16. Activation of MMP-2 has been
associated with cell migration. There is, however,
no linear correlation between active MMP-2
levels and cell migration. High levels of active
MMP-2 result in excessive extracellular matrix
and impaired cell migration while cells with
intermediate active MMP-2 levels demonstrate
efficient cell migration17. Thus, haptoglobin may
provide cells with an additional regulation of
MMP-2 activity6, thereby providing the correct
Expression of arterial haptoglobin isoforms
To investigate variations in haptoglobin
glycosylation, 2D gel electrophoresis and lectin
affinity blotting was performed. Haptoglobin is
a tetrameric glycoprotein consisting of two α-
and two β-chains (α
2
β
2
). After separation of
total protein samples on 2D gel, a train of spots
was detected representing different glycoforms
of haptoglobin β-chain and two smaller spots
representing the α-chains of haptoglobin. The
2D gels demonstrated that there were no differen-
ces in the number or position of arterial hapto-
globin β-chains between control (figure 4A) and
balloon dilated arteries (figure 4B) although total
haptoglobin protein levels increased after balloon
dilation. There were, however, large differences
in localization of haptoglobin β-chains in arterial
(figure 4A+B) and liver samples (figure 4C).
Using the α-chains as a landmark on the gel,
arterial haptoglobin β-chains were mainly located
towards pH 4.5 while liver haptoglobin β-chains
were located towards pH 5.5. In serum samples,
both the liver and arterial haptoglobin β-chains
Figure 4. Differential expression of rabbit haptoglobin b-chains
Shown are western blots for haptoglobin protein after 2D-gel
electrophoresis from A) control artery, B) balloon dilated artery, C) the
liver and D) serum. The arrow head indicates haptoglobin α-chains, the
arrow indicates haptoglobin β-chains.
Figure 5. Tissue-specific glycosylation of haptoglobin
Shown is the presence of specific sugar groups on arterial haptoglobin
using western blotting with haptoglobin antibodies (A) and the lectins
GNA (B) and lotus tetragonolobus (C). a=artery, l=liver, s=serum.
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substrate necessary for optimal cell migration.
Haptoglobin mRNA is only expressed by
adventitial cells after balloon dilation and not
by cells in the media or neointimal layer. These
positive cells are probably fibroblasts, which are
also the haptoglobin producing cells in the
arterial wall after flow changes6. The adventitia
is the first arterial layer that responds to arterial
injury with enhanced extracellular matrix
accumulation, cell proliferation18 and MMP
expression19. Moreover, adventitial fibroblasts
migrate towards the subendothelial space,
thereby contributing to neointima formation20-21.
The adventitial expression of MMPs combined
with elevated haptoglobin levels may facilitate
the migration of adventitial fibroblasts.
Until recently, the liver was thought to be the
major site of haptoglobin synthesis. However,
haptoglobin is also expressed at basal levels in
extrahepatic tissues and expression can be
induced by lipopolysaccharide (LPS)4-5. Liver
haptoglobin expression can be induced during
systemic inflammation and liver injury which
might explain the observed elevations in serum
haptoglobin concentrations. However, until now
it was unclear whether liver haptoglobin
expression is also elevated after local stimulation
of haptoglobin in extrahepatic tissues. In this
study, we compared the relative levels of liver
and arterial haptoglobin synthesis. Arterial
haptoglobin expression increased early after
balloon dilation at mRNA and protein levels. In
contrast, liver haptoglobin mRNA and protein
expression remained constant after balloon
dilation. We infer that increased local arterial
haptoglobin synthesis is responsible for the
observed increases in arterial haptoglobin levels
and that this is not due to extravasation of hapto-
globin from serum.
Previously, an association had been found
between altered glycosylation patterns of hapto-
globin and the development and progression of
various pathological processes12. Moreover, the
type of glycosylation appeared to have prognos-
tic values in certain pathological diseases22-23.
However, the liver was always thought to be the
production site of these abnormally glycosylated
haptoglobin forms. In this study, we demonstrate
that the rabbit artery produces an unique set of
haptoglobin β-chains compared to the liver and
that both forms can be detected in serum. This is
in accordance with the human situation in liver
and serum samples, as found in the SWISS 2D-
PAGE database (http://www.expasy.ch/ch2d).
Lectin affinity blotting revealed that only arterial
haptoglobin reacted to the lectins GNA and lotus
tetragonolobus, confirming that differences in
glycosylation are responsible for the specific
arterial and liver haptoglobin glycoforms. This
is in accordance with another study24 showing
that different haptoglobin β-chains react with
different affinity to lectins. Serum samples also
reacted positive with the used lectins, demon-
strating that arterial haptoglobin is secreted into
the serum. Since alterations in glycosylation are
known to modify function, structure or targeting
of proteins25-27, it is conceivable that arterial
haptoglobin has a different function compared
to haptoglobin produced in the liver. However,
the functional role of tissue-specific differences
in haptoglobin glycosylation remains to be
elucidated.
In summary, we found increased haptoglobin
expression in the adventitia of rabbits after
balloon dilation. Localization of arterial haptoglo-
bin expression was confirmed in human athero-
sclerotic coronary arteries, supporting a role for
haptoglobin in pathological arterial restructuring.
Furthermore, we demonstrated that arteries
produce a unique subset of haptoglobin β-chains
compared to liver samples. Since human athero-
sclerotic arteries also express haptoglobin, this
might point to a potential role for arterial hapto-
globin glycoforms as a serum marker for athero-
sclerotic disease28.
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Serum haptoglobin glycosylation patterns are not associated with
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Background: Haptoglobin is an acute phase glycoprotein that is expressed in arteries and can
be induced after blood flow changes or arterial injury. Arterial haptoglobin is differentially
glycosylated compared to liver derived haptoglobin, allowing discrimination in serum samples.
Previously, alterations in serum haptoglobin glycosylation have been associated with the
progression and outcome of chronic inflammatory diseases. As atherosclerosis is an inflammatory
disease, we investigated alterations in serum haptoglobin glycosylation patterns in atherosclerotic
disease. Materials and methods: Serum was isolated from 80 atherosclerotic patients and 77
age, sex and risk factor matched control patients. All patients underwent non-invasive carotid
artery duplex imaging to measure intima-media thickness (IMT). Total serum haptoglobin
levels were measured using a sandwich ELISA. Lectin affinity blotting with four different
lectins was used to investigate serum haptoglobin glycosylation patterns. Results: Total serum
haptoglobin levels did not differ between atherosclerotic and control patients (p=0.63). In
addition, no differences were found in serum haptoglobin glycosylation patterns (p>0.38). Neither
total serum haptoglobin levels nor serum haptoglobin glycosylation patterns were associated
with IMT in atherosclerotic or control patients (p>0.10). Conclusion: Serum haptoglobin
glycosylation patterns do not differ in patients suffering from atherosclerotic disease indicating
that it is unlikely to be a predictive serum marker for atherosclerotic disease.
Introduction
Atherosclerosis is being recognized as the major
cause of death in Western society. Several studies
have indicated that serum proteins can serve as
markers for cardiovascular disease1-2. Hapto-
globin is one of the major serum glycoproteins
and levels are often increased during inflammation,
tissue damage and diseases like cancer and
arthritis3. Although haptoglobin is generally
believed to be a liver-specific protein, it is also
expressed at basal levels in various other extrahe-
patic tissues4-5 including the arterial system6.
Moreover, arterial haptoglobin expression is
secreted into the serum and can be induced after
sustained blood flow changes6.
Studies investigating the feasibility of using
serum haptoglobin levels as a marker for
atherosclerosis revealed conflicting data. Snyder
et al7 found increased haptoglobin levels in
patients with previous myocardial infarcts
compared to healthy controls. This was suppor-
ted by Lindberg et al8 who described an
association between serum haptoglobin levels
and the prevalence of atherosclerotic disease. In
contrast, Mori et al1 found that serum haptoglo-
bin levels were not associated with the severity
of coronary atherosclerosis.
Atherosclerosis is considered to be an inflamma-
tory disease9. Interestingly, other chronic
inflammatory diseases like arthritis, Crohn’s
disease and ulcerative colitis are characterized
by alterations in serum haptoglobin glycosylation
patterns10-12, even in the absence of changes in
total serum haptoglobin levels. In addition, serum
haptoglobin glycosylation patterns can vary
between different diseases10, 13 and appear to be
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predictive for the progression and outcome of
inflammatory diseases10, 14. Previously, we de-
monstrated in rabbits that arterial haptoglobin
has a unique glycosylation pattern compared to
liver haptoglobin and that these arterial hapto-
globin glycoforms can be detected in the serum
(unpublished results). However, it is not known
whether glycosylation patterns of total serum
haptoglobin will change during atherosclerotic
disease.
Based on the tissue-specific glycosylation of
haptoglobin and previous studies on alterations
in serum haptoglobin glycosylation in other
inflammatory diseases, we hypothesized that
serum haptoglobin glycosylation patterns might
alter in atherosclerotic disease. In addition, total
serum haptoglobin levels and haptoglobin
glycosylation patterns were associated with
carotid artery intima-media thickness, a surrogate
marker for the extent of atherosclerotic disease.
Material and methods
Patient population
All patients were participants of the Second Manifestations of ARTerial
disease (SMART) study, an ongoing, single-center, prospective cohort
study of approximately 3500 patients referred to the University Medical
Center Utrecht for the first time because of atherosclerotic vascular
disease or for treatment of atherosclerotic risk factors.
From the SMART study database, 80 atherosclerotic patients with a
history of atherosclerotic vascular disease, atherosclerotic disease at
the time of hospital-entry and one cardiovascular risk factor were
selected. In addition, these patients were also screened for the presence
of clinically silent atherosclerotic lesions in the carotid and femoral
arteries and aorta. Atherosclerotic luminal narrowing in the femoral
artery was evaluated by measuring the ratio of the systolic blood pressure
measured at the ankle to the systolic blood pressure measured in both
arms (ankle-brachial pressure index, ABPI). When patients had a
lowered ABPI (<0.9), they were classified having silent atherosclerosis.
Plaques and stenosis of the common and internal carotid arteries on both
sides were measured with Doppler-assisted Duplex scanning. When
the carotid stenosis exceeded the 70%, patients were diagnosed having
clinically silent atherosclerosis. Furthermore, ultrasonography of the
abdomen was performed to measure the anteroposterior juxtarenal
diameter and the distal anteroposterior diameter of the aorta. As a control
group, 77 age-, sex- and risk factor matched patients not having clinically
evident or silent atherosclerosis were selected.
Patient sera
Blood samples were collected from each individual and serum was
isolated. Samples were stored in liquid nitrogen until analysis.
Intima media thickness measurements
In all patients, intima-media thickness (IMT) was measured in the left
and right common carotid arteries. The left and right common carotid
arteries were examined in anterolateral, posterolateral and mediolateral
direction using a ATL Ultramark 9 (Advanced Technology Laboratories)
equipped with a 10 MHz linear array transducer. The total intima-media
surface of the selected area was calculated on-line using built-in software
of the ultrasound system. The mean IMT of the six measurements in each
patient was calculated. Patients were divided in quartiles on the basis of
IMT.
Haptoglobin enzyme-linked immunosorbent assay (ELISA)
In microtiter plates, wells were coated o/
n
 at room temperature (RT) with
1 ng/ml goat-α-human haptoglobin (DAKO). After coating, the wells
were washed three times with PBST (PBS-0.1% Tween-20) and incubated
for 30 minutes with 1% block solution (PBST+1% non-fat dry milk).
Wells were incubated for 1 hour at 37°C with patient serum (1:500.000
dilution in 1% block solution), followed by three washes with PBST.
Subsequently, the wells were incubated for 1 hour at 37°C with goat-α-
human haptoglobin (1:4000, Sigma) and rabbit-α-goat peroxidase
(1:10.000, Sigma). After three washes with PBST, ortho-phenylene
diamine/H
2
O
2
 substrate solution was added. The colorimetric reaction
was stopped by adding 4M H
2
SO
4
 and the optical density was measured
at 490/650 nm. Serum haptoglobin concentrations were calculated using
a standard curve containing four reference concentrations of purified
human serum haptoglobin (Sigma).
Haptoglobin glycosylation: lectin affinity blotting
Serum samples (0.1 µl/lane) were separated under reducing conditions
on a 10% sodium dodecyl sulfate polyacrylamide gel. Proteins were
electrophoretically transferred in blotting buffer (3.03 g/L Tris 14.4 g/
L Glycine, 20% methanol) onto Hybond ECL (Amersham). Incubation
with biotinylated lectins GNA, SNA, WGA and lotus tetragonolobus
(1:1000, EY Laboratories) occurred in 5% block solution  (PBST+5%
non-fat dry milk) for 1 hour at RT followed by three washes with PBST.
Incubation was continued with streptavidin peroxidase (1:1000, SBA)
for 1 hour at RT in 5% block solution, followed by three washes with
PBST and a single wash with PBS. Detection occurred using the enhanced
chemiluminescence kit (NEN Life Science products) and exposure to X-
Omat Blue XB-1 films (Kodak).
Statistics
Data are presented as mean±standard error of the mean (sem). The
independent t-test was used to compare total serum haptoglobin levels
and serum haptoglobin glycosylation between control and atherosclerotic
patients. Linear regression analysis was performed to investigate the
relation between mean IMT and serum haptoglobin levels and
glycosylation patterns in the two patient groups. One-way ANOVA was
performed to investigate differences in serum haptoglobin levels and
glycosylation patterns between the quartiles of IMT. P values <0.05
 control atherosclerosis 
 
no. of subjects (male) 
 
77 (38) 
 
80 (40) 
age, years 56.8 ± 9.4 59.7 ± 10.8 
BMI, kg/mm2 26.1 ± 4.2 26.1 ± 3.3 
smoking, no. of subjects 
 
51 72 
(a)symptomatic carotid stenosis 0 39 
peripheral arterial disease 0 31 
abdominal aortic aneurysm 
 
0 6 
hypertension, no. of subjects 5 5 
diabetes, no. of subjects 7 7 
hyperlipidemia, no. of subjects 
 
65 68 
systolic blood pressure, mm Hg 134 ± 16 142 ± 17 
diastolic blood pressure, mm Hg 80 ± 9 76 ± 9 
mean IMT, mm 0.8 ± 0.2 0.9 ± 0.3 
ABPI <0.9, no. of subjects 
 
0 35 
cholesterol, mmol/L 6.8 ± 2.1 5.7 ± 1.2 
HDL cholesterol, mmol/L 1.1 ± 0.4 1.1 ± 0.3 
triglycerides, mmol/L 3.1 ± 3.0 2.0 ± 0.9 
 
Table I. Patient characteristics of the study groups
were considered to be statistically significant.
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glycoproteins (figure 2A). Analysis of serum
haptoglobin glycosylation revealed no diffe-
rences in haptoglobin glycosylation patterns
between atherosclerotic and control patients for
all four tested lectins (for all groups p>0.38)
(figure 2B), even after adjustment for total serum
haptoglobin levels.
Relation between haptoglobin and IMT
Linear regression analysis did not reveal any
correlation between total serum haptoglobin
levels and IMT in atherosclerotic and control
patients (p>0.10) (data not shown). In addition,
no association was found between serum
haptoglobin glycosylation and IMT (for all
groups p>0.17). Subdivision of IMT into
quartiles neither revealed a relation between IMT
and total serum haptoglobin levels nor between
IMT and glycosylation patterns (table II).
Discussion
In the present study, we measured total serum
haptoglobin levels and glycosylation patterns in
80 atherosclerotic patients and 77 age, sex and
risk factor matched controls. However, no
association was found between total serum
haptoglobin levels and atherosclerotic disease or
IMT in the carotid artery, which is a surrogate
measure for the extent of atherosclerosis. In
addition, there were no differences in serum
haptoglobin glycosylation patterns between
atherosclerotic and control patients. Serum
haptoglobin glycosylation patterns were not
related to mean IMT.
Based on previous studies, we hypothesized that
an association between serum haptoglobin
glycosylation patterns and atherosclerotic disease
might be present. Our hypothesis was based on
three observations. First, haptoglobin is ex-
pressed in arteries and can be induced after
sustained blood flow changes6. Secondly, arterial
Results
Patient characteristics
The patient characteristics are summarized in
table I. Atherosclerotic and control patients were
matched for age, sex and risk factors. Since there
were no differences in serum haptoglobin levels
and glycosylation patterns between males and
females, the data from both sexes were pooled.
Serum haptoglobin levels and glycosylation
patterns
Serum haptoglobin levels ranged from 0.01 to
7.80 g/L. There were no differences in serum
haptoglobin levels between patients with
atherosclerosis and control patients (p=0.63)
(figure 1). Overall, serum haptoglobin levels
were within the normal range between 0.4 to 3.8
g/L16 (mean 1.8±0.2 g/L). Using a cut-off point
of serum haptoglobin levels <0.4 g/L, four
atherosclerotic patients and three control patients
revealed low but detectable levels of serum
haptoglobin and could be classified as hypo-
haptoglobinemic.
Lectin affinity blotting was used to measure
haptoglobin glycosylation as lectins recognize
specific carbohydrates that are present on
Figure 2. Glycosylation patterns of serum haptoglobin in
atherosclerotic and control patients
A) Lectin-affinity blot using lectin GNA (representative for the other
lectins used in this study). B) Western blot using a goat-α-human
haptoglobin antibody. C) Western blot using a goat-α-human haptoglobin
antibody. Blocking the goat-α-human haptoglobin antibody with 4 µg
purified human serum haptoglobin resulted in the disappearance of
haptoglobin bands. Lane 1= purified human haptoglobin, lane 2=
atherosclerotic patient, lane 3= control patient. D) Glycosylation patterns
of serum haptoglobin from control (black bars) and atherosclerotic (grey
bars) patients.
  
1e 
 
2e 
IMT ( quartiles) 
3e 
 
4e 
ANOVA 
P 
      
haptoglobin 2.0±0.3 1.9±0.3 1.8±0.3 1.9±0.3 0.90 
GNA 5.8±0.2 5.3±0.2 5.5±0.2 5.4±0.2 0.33 
SNA 2.7±0.2 2.8±0.1 2.7±0.1 2.8±0.2 0.88 
WGA 7.2±0.2 7.3±0.2 7.7±0.4 7.2±0.3 0.55 
lotus  5.0±0.3 5.3±0.3 5.2±0.3 5.7±0.3 0.58 
 
Table II. Association between common carotid intima-media
thickness (IMT) and total serum haptoglobin levels or
glycosylation patterns
P values <0.05 are considered to be statistically significant
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haptoglobin is differentially glycosylated com-
pared to liver-derived haptoglobin and these arte-
rial haptoglobin glycoforms can be detected in
the serum (unpublished results). Finally, several
sero-epidemiological studies have demonstrated
that haptoglobin glycosylation patterns change
during chronic inflammatory diseases10-11, 13,
suggesting that serum haptoglobin glycosylation
patterns reflect the presence of active inflam-
matory disease.
Although there seems to be a relation between
serum haptoglobin glycosylation patterns and the
outcome of inflammatory diseases10-11, 13, no rela-
tion in time is described for haptoglobin
glycosylation and the inflammatory status of pa-
tients. Fucosylation of haptoglobin is specifically
increased in patients with active arthritis and
not in patients with inactive arthritis16. No asso-
ciation has been described between haptoglobin
glycosylation and disease activity in patients with
Crohn’s disease17. Thus, activity of disease might
influence temporal glycosylation patterns of hap-
toglobin. The patient population that was selec-
ted for the present study all entered the hospital
for a current manifestation of atherosclerotic
disease suggesting that the negative results cannot
be explained by an inactive phase of atheroscle-
rotic disease.
In the present study, we investigated four
different serum haptoglobin glycosylation
patterns with relationship to with atherosclerotic
disease. Alterations in sialylation, glucosaminy-
lation and fucosylation of serum haptoglobin
(respectively lectins SNA, WGA and lotus
tetragonolobus) have previously been described
to be associated with inflammatory diseases10,
13-14, 16, 18 . In addition, differences in mannosyl-
ation (lectin GNA) have been used to distinguish
arterial haptoglobin from liver-derived hapto-
globin in rabbits (unpublished results). Although
we did not observe an association between hapto-
globin glycosylation and atherosclerotic disease,
it is still possible that other serum haptoglobin
glycosylation patterns are associated with athero-
sclerotic disease13.
Atherosclerosis involves a chronic inflammatory
process that takes several years and gradually
progresses from neointima formation to advanced
atherosclerotic lesions. This slow development
of atherosclerotic lesions may not be sufficient
to induce arterial haptoglobin expression or only
at very low levels. Although haptoglobin ex-
pression has been demonstrated in atherosclerotic
arteries, low arterial expression levels will make
it difficult to detect changes in the subpopulation
of arterial-derived haptoglobin in serum due to
the high baseline levels of haptoglobin in serum
(0.4-2.6% of total plasma proteins). In addition,
arterial haptoglobin expression may only be
induced after severe events like plaque rupture,
which only occurs in small parts of the arterial
system.
Animal models have demonstrated that arterial
haptoglobin expression is increased early after
flow changes6 and returns to baseline levels
within 2-3 weeks after induction. Arterial
restructuring, in contrast, continues to progress
up to 4 weeks after balloon angioplasty, implying
that haptoglobin is only important during the
initiation of arterial restructuring. In general,
patients with atherosclerosis enter the hospital
years after the initiation of atherosclerosis as the
progression towards severe atherosclerotic
plaques takes several years. In this study, we
compared patients with progressed athero-
sclerosis to healthy control patients. However,
it might be interesting to investigate whether total
serum haptoglobin levels or haptoglobin
glycosylation patterns in patients early after
balloon angioplasty or stenting are predictive for
the occurrence of (in-stent) restenosis.
The absence of a relation between total serum
haptoglobin levels and atherosclerosis and an
equal distribution of hypohaptoglobinemic
people between the control and atherosclerotic
patient groups suggests that haptoglobin is not
involved in arterial restructuring during athero-
sclerosis. However, several studies have indicated
that haptoglobin does play an important role
during arterial restructuring. Although hapto-
globin knockout mice are viable and demonstrate
no obvious symptoms19, these mice have im-
paired arterial restructuring after blood flow
changes6. In addition, haptoglobin polymor-
phisms in humans have been associated with
various cardiovascular diseases including a higher
prevalence of coronary artery disease20 and more
restenosis after balloon angioplasty21 or sten-
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ting22. These studies indicate that haptoglobin
may not be essential for normal vessel wall
homeostasis but does play an important role after
arterial injury and the subsequent repair process.
In summary, we have demonstrated that total
serum haptoglobin levels and haptoglobin
glycosylation patterns are not associated with
atherosclerosis. Hence, serum haptoglobin
glycosylation patterns are unlikely to be a pre-
dictive serum marker for atherosclerotic disease.
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General discussion
The arterial wall consists of various cell types
that are embedded in extracellular matrix.
Together, cells and extracellular matrix maintain
the structural integrity of the artery. In response
to injury, the artery starts a complex but
controlled healing response including processes
like cell-cell and cell-matrix interactions, cell
migration and remodeling of the extracellular
matrix.
Collagen is the main component of the
extracellular matrix in arteries and plays an
important role during arterial restructuring.
Besides providing the artery with structural
strength1, the composition of collagen fibers is
also vital for controlling many cellular processes
like cell phenotype, protein synthesis and cell
migration2-3. This is, however, a complex system
that requires tight control of collagen turnover.
Intact collagen fibers need to be partially degraded
for cell detachment and cell migration to occur4.
However, total degradation of collagen around
the cell would result in complete cell detachment
and subsequent cell death5. In addition, active
collagen synthesis is essential for cell migration6,
probably by providing cells the correct substrate
to form a temporary matrix that is suitable for
cell migration.
As collagen turnover is important for arterial
restructuring, many studies have investigated the
various pathways involved in collagen synthesis
and degradation7-8. Although some studies
investigated the effect of altered matrix compo-
sition on cell behavior and signaling9-12, most
studies have focussed on matrix turnover itself
and the proteins involved in matrix synthesis
and degradation13-15. There are, however, still
many proteins that play a role during arterial
restructuring that have not been identified yet.
One of the recently identified proteins that is
involved in arterial restructuring is haptoglobin16.
Haptoglobin is expressed at basal levels in the
arterial wall and arterial expression can be induced
after sustained flow changes16 or balloon dilation
(see chapter 2 and 5). Haptoglobin can function
as a gelatinase-inhibitor and haptoglobin defi-
ciency results in diminished cell migration.
Supplementation of exogenous haptoglobin to
haptoglobin knockout cells restores their capacity
to migrate16. In addition, haptoglobin knockout
mice demonstrated delayed arterial restructuring
after sustained flow changes16, suggesting an
important role for haptoglobin during arterial
repair.
Haptoglobin function
Haptoglobin is an acute phase serum protein that
comprises up to 2.6% of the total protein in
serum. Haptoglobin is mostly recognized for its
high binding affinity to hemoglobin17 and
thought to be important for the clearance of free
hemoglobin from the serum. However, clearance
of free hemoglobin from the serum and subse-
quent liver degradation is normal in haptoglobin
knockout mice18, indicating that haptoglobin is
not essential for the clearance of free hemoglobin.
This is in accordance with previous studies de-
monstrating that isolated liver cells take up free
hemoglobin in the absence of haptoglobin19 and
that free hemoglobin is cleared at a faster rate
from the serum than hemoglobin-haptoglobin
complexes20.
Recently, several studies have demonstrated
various other biological functions for haptoglobin
of which some have been related to the high
binding affinity of haptoglobin to hemoglobin.
One of the best described functions of haptoglo-
bin that is related to hemoglobin binding is its
role as antioxidant. The hemoglobin-haptoglobin
complexes reduce the formation of free radicals
like superoxide and hydroxyl that are catalyzed
by heme iron21. Heme iron also catalyzes the
oxidation of lipoproteins which can cause damage
to cells and tissue22. Thus, as a consequence of
the capture of free hemoglobin by haptoglobin,
heme iron is unavailable for iron-driven oxidation
reactions.
The inhibitory effect of haptoglobin on some
enzymes like prostaglandin synthase also appear
to depend on the availability of heme-derived
iron. Binding of free heme controls the peroxidase
activity of prostaglandin synthase, an enzyme
that is inhibited by haptoglobin23-24. However,
the observed inhibition of gelatinase activity by
haptoglobin16 is presumably not related to the
availability of free iron. MMP activity assays
have demonstrated inhibition of gelatinase activity
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by haptoglobin in the absence of heme-derived
iron. In contrast, cell culture experiments demon-
strated that supplementation of iron to cells
results in increased MMP-2 activity25.
Another function of haptoglobin involves the
modulation of the immune response. Haptoglo-
bin expression is induced during inflammation
and has been described to act as a potent
immunosuppressor. Haptoglobin can function as
a natural antagonist for receptor-ligand activation
of the immune system26 and inhibits lectin- or
LPS-induced lymphocyte transformation27.
Furthermore, haptoglobin binds to several cell
types of the immune system and may influence
their function. A specific interaction between
haptoglobin and CD2228 has been described,
which is a B-cell receptor that mediates B-cell
interactions with other cell types. Haptoglobin
can also interact with the Mac-1 (CD11b/CD18)
receptor29 that belongs to the integrin family and
is involved in cell-cell and cell-matrix interactions.
Through interaction with this receptor,
haptoglobin might influence the Th1/Th2 balance
towards a dominant Th1 response30. In addition,
haptoglobin can exert an anti-inflammatory effect
by inhibition of inflammatory mediators like
prostaglandin synthase31 and cathepsins32.
Haptoglobin and tissue repair
Studies investigating the role of haptoglobin in
hemoglobin clearance demonstrated that hapto-
globin knockout mice were more susceptible to
tissue damage and showed delayed tissue repair18
then wild type mice. The possible involvement
of haptoglobin in tissue repair is further suppor-
ted by the observation that haptoglobin knockout
mice have delayed arterial repair after ligation of
the carotid artery16.
The exact mechanism by which haptoglobin
modulates tissue damage and the repair process
is still not known but there are several possible
explanations, based on the various functions that
have been described for haptoglobin. First,
haptoglobin may function as an anti-oxidant
through it’s high affinity binding capacity to
hemoglobin. The increased accumulation of free
hemoglobin in the kidney of haptoglobin knockout
mice during hemolysis results in increased lipid
peroxidation and eventually in tissue injury and
delayed repair18. However, there is no evidence
for increased hemoglobin accumulation in the
carotid artery after ligation16. Secondly, hapto-
globin may influence the tissue healing response
by modulating cell migration. Cell migration is
an important process during the healing
response33 and haptoglobin has been identified
as a natural gelatinase-inhibitor and an important
factor during cell migration16. Supplementation
of exogenous haptoglobin to haptoglobin knock-
out cells restored their capability to migrate. In
addition, haptoglobin stimulates angiogenesis34
which also depends on cell migration.
Haptoglobin and cell migration
The involvement of haptoglobin, as an endoge-
nous gelatinase inhibitor, in cell migration seems
paradoxical as many studies have linked cell
migration and cell invasion to increased MMP
activity. It is generally believed that degradation
of pre-existing collagen fibers by MMPs is
necessary for cell migration to occur. However,
uncontrolled degradation could impede this
process, since extracellular matrix components
are required for cell migration and cell survival.
Nowadays, there is evidence that only limited
degradation of the extracellular matrix is suffi-
cient to promote cell migration and subsequent
matrix remodeling. Degradation of a gelatin matrix
by migrating cells is not random or total but
involves the reorganization of extracellular
matrix35. Furthermore, contraction of the extra-
cellular matrix requires only subtle rearrange-
ments of extracellular matrix 36-37. Apparently,
MMPs do not randomly degrade extracellular
matrix but are involved in a highly localized,
tightly controlled and efficient reorganization of
the extracellular matrix to provide the correct
substrate necessary for cell migration or matrix
remodeling. Moreover, there is increasing
evidence that soluble MMPs are less active than
cell-surface associated MMPs38, suggesting that
MMP-mediated degradation of the extracellular
matrix is restricted to the immediate surrounding
of cells39-40.
Several studies have demonstrated that non-
selective MMP inhibitors, either synthetic
compounds41-42 or the endogenously expressed
TIMPs43-44, can inhibit cell migration. However,
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these studies did not focus on the role of individual
MMPs, making it difficult to say whether
collagenases, gelatinases or a combina-tion of both
classes of MMPs are necessary for cell migration.
Studies investigating the role of individual MMPs
in cell migration after arterial injury are descrip-
tive and only demonstrate a relation in expression
patterns over time between increased MMP
activity and cell migration but not a functional
relationship. In addition, studies using MMP
knockout mice failed to demonstrate an essential
role for individual MMPs in cell migration. Most
MMP knockout mice lack a lethal embryonic
phenotype and deliver healthy offspring with
limited morphologic abnorma-lities45-49. The only
exception is the deletion of MT1-MMP which
causes dwarfism, arthritis and connective tissue
diseases related to impaired collagen degrada-
tion50. Apparently, multiple back-up mechanisms
exist that can compensate for the loss of a single
MMP.
The exact mechanism by which MMPs regulate
cell migration remains to be elucidates. As hapto-
globin can inhibit gelatinase activity, it may
provide the necessary fine-tuning of gelatinase
activity that is required during the tightly
controlled process of cell migration. Inhibition
of gelatinase activity by haptoglobin will result
in the accumulation of gelatin around the cell
that can serve as a temporary matrix for cell
migration (figure 1). In contrast, nonselective
MMP inhibitors inhibit more than one class of
MMPs or may exert their effect by inhibiting
MMPs that are more upstream in the MMP
cascade like the collagenases. This may result in
complete inhibition of gelatin formation and thus
inhibition of cell migration due to the absence
of the correct substrate.
Haptoglobin glycosylation
Haptoglobin is a glycoprotein with 4 N-linked
glycosylation sites on the β-chain. Previously,
sero-epidemiological studies have demonstrated
alterations in serum haptoglobin glycosylation
that have been associated with disease develop-
ment and progression51. Haptoglobin is highly
fucosylated in ovarian cancer52 and inflammatory
joint diseases53 whereas patients with Crohn’s
disease have increased sialylated serum
haptoglobin levels54. As haptoglobin was thought
to be produced mainly in the liver and secreted
into the serum, it was always assumed that the
abnormally glycosylated haptoglobin was
produced by the liver. However, recent studies
have demonstrated that haptoglobin is also locally
expressed at extrahepatic sites16, 55 and that local
haptoglobin expression is increased during
pathological processes (see chapter 4) or inflam-
mation56, suggesting that extrahepatic haptoglobin
production can also be responsible for the
alterations in serum haptoglobin glycosylation
patterns.
Two-dimensional gel analysis and lectin affinity
blotting demonstrated that extrahepatic tissues
can produce distinct haptoglobin glycoforms
compared to liver-derived haptoglobin (see
chapter 5). In addition, these artery-derived
haptoglobin glycoforms can be detected in the
serum. As atherosclerotic arteries produce
haptoglobin, this implies that serum haptoglobin
glycosylation patterns may be used as a marker
for cardiovascular disease. Unfortunately, we
observed no alterations in total serum haptoglo-
bin levels or serum haptoglobin glycosylation
Figure 1. Schematic diagram of the hypothesized gelatinase-
inhibition of haptoglobin.
Inhibition of the gelatinases MMP-2 and MMP-9 by haptoglobin results
in improved cell migration and arterial restructuring. Dashed lines
indicate proteins and pathways involved in the formation of gelatin.
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patterns between atherosclerotic and control
patients (see chapter 6). This may be related to
no or only small increases in haptoglobin expres-
sion in atherosclerotic arteries. As haptoglobin
is one of the major serum proteins and present at
relative high concentrations in the serum, this
makes it difficult to detect small differences in
serum haptoglobin levels.
Although the general role of protein glycosylation
has not been completely established, recent
studies have indicated that posttranslational
glycosylations may exert multiple effects.
Besides modulation of protein solubility57,
protein folding58, cell surface expression59-60 and
stabilization of protein conformation61, glycosy-
lation can also modulate biological functions of
proteins. Glycosylation of MD-2 and Toll-like
receptor 4 is essential for binding of LPS to MD-
2/TLR-4 complexes and cell activation62. Ligand-
binding63 as well as ligand-induced receptor
internalization64 is modulated by glycosylation.
Furthermore, glycosylation can influence enzyme
activity by increasing enzyme stability65 and
modifying of catalytic activity66-67.
The finding that arteries produce a unique set of
haptoglobin glycoforms suggests that local
haptoglobin expression provides the tissue with
a source of functionally different haptoglobin
compared to serum haptoglobin. However, no
information is available about the function of the
glycosylation sites in haptoglobin and it remains
to be elucidated whether alterations in hapto-
globin glycosylation can modulate haptoglobin
function.
As haptoglobin phenotype in humans is deter-
mined by the haptoglobin α-chain whereas
glycosylation occurs on the haptoglobin β-chain,
it is not likely that glycosylation will directly
influence the observed functional differences
between the haptoglobin phenotypes. However,
it is possible that formation of multimeric hap-
toglobin complexes is influenced by the presence
or absence of specific sugar groups on the hap-
toglobin β-chain which may stochiometrically
inter-fere with haptoglobin function.
Haptoglobin in cardiovascular disease
People with haptoglobin deficiency (anhapto-
globinemia) as well as haptoglobin knockout mice
are viable and demonstrate no higher risk to
cardiovascular disease during normal live. How-
ever, haptoglobin knockout mice show delayed
arterial restructuring after sustained flow changes.
In addition, haptoglobin phenotype has been
associated with the development of coronary
artery disease68 and restenosis after balloon
angioplasty69 or stenting70. Therefore, we infer
that artery-derived haptoglobin is not essential
during normal vessel wall homeostasis but may
play an important role in pathological arterial
processes like atherosclerosis and arterial restruc-
turing after balloon angioplasty.
Although haptoglobin is present in the serum of
all mammals, only humans have a polymorphism
with three phenotypes due to the presence of a
haptoglobin α2-chain. Interestingly, the three
main phenotypes of haptoglobin (Hp1-1, Hp2-1
and Hp2-2) are characterized by differences in
biophysical and biochemical properties. A
possible explanation for the involvement of
haptoglobin phenotype in cardiovascular disease
is oxidative stress which has been implicated in
the initiation and pathogenesis of atheroscle-
rosis71. The three phenotypes of haptoglobin
have small differences in their antioxidant
capacity with Hp1-1 providing the best pro-
tection against oxidative stress due to free
hemoglobin72. The relative small differences in
antioxidant capacity in vitro may be dramatically
amplified in vivo due to the size of haptoglobin
multimers. Smaller haptoglobin multimers like
monomeric haptoglobin 1-1 have better sieving
capacities to get into extravascular fluids or tissue
and can therefore better function as an
antioxidant. In addition, phenotypic differences
for haptoglobin have been described in modu-
lation of the immune response73 and for the
angiogenic properties of haptoglobin34. Hence,
haptoglobin phenotype may influence the
development and progression of cardiovas-cular
disease through several mechanisms instead of
just one.
Concluding remarks and future aspects
Collagen turnover is an important process during
arterial restructuring. Using a subtraction PCR
to identify new proteins involved in collagen
turnover, we demonstrated increased arterial
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haptoglobin expression after sustained flow
changes or arterial injury. Haptoglobin was found
to be a gelatinase-inhibitor and involved in cell
migration and arterial restructuring. In addition,
arteries produce specific haptoglobin b-chain
glycoforms that may imply functional differences
between liver- and arterial-derived haptoglobin.
We have previously demonstrated that arteries
produce specific haptoglobin glycoforms
compared to liver-derived haptoglobin. Although
it is known for other proteins that changes in
glycosylation can alter protein function, we did
not demonstrate that alterations in haptoglobin
glycosylation modulate haptoglobin function.
Therefore, it would be interesting to study arterial
haptoglobin glycosylation in more depth and
investigate whether differential glycosylation of
arterial haptoglobin indeed modulates the func-
tion of haptoglobin.
Although we did not observe a relation between
total haptoglobin serum levels and serum hapto-
globin glycosylation patterns, we did not exclude
the possibility that haptoglobin can function as
a serum marker for acute arterial restructuring
after balloon angioplasty or stenting. As arterial
haptoglobin is involved in arterial restructuring,
changes in total serum haptoglobin levels or
haptoglobin glycosylation patterns in patients
early after balloon angioplasty or stenting may
be predictive for the occurrence of (in-stent)
restenosis.
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Summary
Several studies have demonstrated that collagen
turnover is important during arterial restruc-
turing. However, the precise mediators involved
in collagen turnover are still not known. In order
to develop specific inhibitors to prevent arterial
restructuring, it is essential to get a better under-
standing of the molecular pathways involved in
collagen turnover. We used a subtraction PCR to
identify new candidate proteins that are involved
in arterial restructuring and to get a better insight
in these pathways. One of the identified proteins
is the acute phase glycoprotein haptoglobin. In
this thesis, we investigated the arterial expression,
regulation and function of haptoglobin.
Chapter 1 is a general introduction that provides
an overview about the role of collagen turnover
in arterial restructuring after balloon angioplasty.
In addition, background information is given
about haptoglobin.
Although many studies have demonstrated an
essential role for collagen turnover during arterial
restructuring, there are still unidentified proteins
that are involved in collagen turnover. In
chapter 2, subtraction PCR is used as an open
approach to identify novel, differentially
expressed genes involved in collagen turnover
and cell migration during arterial restructuring.
Haptoglobin was one of the identified genes and
found to be expressed by adventitial fibroblasts,
early after flow changes. In vitro assays demon-
strated that haptoglobin is a gelatinase inhibitor
and important for cell migration. Furthermore,
arterial restructuring after flow changes was
delayed in haptoglobin knockout mice.
Previous studies have mainly investigated the
regulation of haptoglobin expression in the liver.
The study described in chapter 3 was designed
to identify the mediators involved in arterial
haptoglobin expression after flow changes.
Inhibition of NO synthesis resulted in decreased
arterial haptoglobin expression after flow
changes, coinciding with decreased arterial IL-
6 expression. IL-6 knockout mice were used to
confirm a regulatory role of IL-6 in arterial
haptoglobin expression. As haptoglobin
expression was normal in the IL-6 knockout mice,
this points to backup mechanisms for the regula-
tion of arterial haptoglobin expression.
Cell migration and remodeling of the extra-cellular
matrix are important during various physiological
and pathological processes. As haptoglobin
plays an important role in cell migration and
remodeling of the extracellular matrix, we
investigated in chapter 4 the local expression of
haptoglobin in two pathological tissues that are
characterized by these two processes. Pre-
viously, sero-epidemiological studies have
demonstrated that arthritis and cancer are charac-
terized by increased serum haptoglobin levels.
In this study, we demonstrated that local hapto-
globin expression is also locally increased in
arthritic and cancer tissue.
Haptoglobin is thought to be produced mainly
in the liver. However, several studies have also
described extrahepatic haptoglobin expression.
As haptoglobin is present at high concentrations
in the serum, the function of local haptoglobin
expression is not completely understood. In
chapter 5, we investigated whether alterations
in haptoglobin glycosylation could explain the
necessity of local haptoglobin expression in the
arterial wall. Haptoglobin expression and glyco-
sylation was studied in balloon dilated rabbit
arteries. Balloon dilation increased arterial
haptoglobin expression within the first two weeks
after injury whereas liver haptoglobin expression
remained constant. There were no differences in
arterial haptoglobin glycosylation after balloon
dilation. However, arterial haptoglobin was
differentially glycosylated compared to liver
haptoglobin and these arterial haptoglobin
glycoforms could be detected in the serum.
Previously, alterations in serum haptoglobin
glycosylation have been associated with the
progression and outcome of different diseases.
In chapter 6, we investigated alterations in serum
haptoglobin glycosylation patterns in atheroscle-
rotic patients. There were no significant
differences in total serum haptoglobin levels or
serum haptoglobin glycosylation patterns be-
tween patients with atherosclerosis and patients
with only risk factors. In addition, no relation
was found between total serum haptoglobin
levels and glycosylation patterns with intima-
media thickness in the carotid artery, which is a
measure for the extent of atherosclero-sis. These
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results indicate that serum haptoglobin glycosy-
lation patterns are not suitable to use as a serum
marker for atherosclerotic disease.
Chapter 7 is a general discussion of the results
from the aforementioned studies.
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Samenvatting
Meerdere studies hebben aangetoond dat de
omzetting van collageen belangrijk is tijdens
herstructurering van de vaatwand. Het is echter
nog steeds niet bekend welke regulatoren precies
een rol spelen in de omzetting van collageen.
Voor de ontwikkelen van specifieke remmers om
herstructurering van de vaatwand te voorkomen
is een beter begrip nodig van alle moleculaire
processen die betrokken zijn bij de omzetting
van collageen. We hebben gebruik gemaakt van
een subtractie PCR om nieuwe kandidaat
eiwitten te identificeren die betrokken zijn bij
de herstructurering van de vaatwand en om een
beter begrip te krijgen in de processen die hierbij
van belang zijn. Een van de eiwitten die is
opgepikt m.b.v. de subtractie PCR is het acuut
fase eiwit haptoglobine. In dit proefschrift
beschrijven we de arteriële expressie, regulatie
en functie van haptoglobine.
Hoofdstuk 1 is een algemene inleiding die een
overzicht geeft over de rol van de omzetting van
collageen tijdens herstructurering van de vaat-
wand na dotteren. Daarnaast wordt achtergrond-
informatie gegeven over haptoglobine.
Hoewel veel studies hebben aangetoond dat
omzetting van collageen belangrijk is voor her-
structurering van de vaatwand, zijn er nog steeds
niet geïdentificeerde eiwitten die betrokken zijn
bij de omzetting van collageen. In hoofdstuk 2
wordt een subtractie PCR gebruikt om nieuwe
eiwitten te ontdekken die verhoogd of verlaagd
tot expressie komen en betrokken zijn bij de
omzetting van collageen en cel migratie tijdens
herstructurering van de vaatwand. Een van de
opgepikte eiwitten is haptoglobine dat vlak na
veranderingen in de bloedstroom wordt
aangemaakt door fibroblasten in de adventitia. In
vitro studies toonden aan dat haptoglobine gelati-
nases kan remmen en een belangrijke rol speelt
tijdens cel migratie. Daarnaast werd aangetoond
dat herstructurering van de vaatwand vertraagd
is in haptoglobine knockout muizen.
Eerdere studies hebben voornamelijk de regulatie
van haptoglobine synthese bestudeerd in de lever.
De studie die beschreven wordt in hoofdstuk 3
was opgezet om regulatoren te identificeren die
betrokken zijn in de expressie van haptoglobine
in de vaatwand na veranderingen in de
bloedstroom. Remming van NO synthese leidde
tot verlaagde haptoglobine expressie na verande-
ring in bloedstroom, tegelijkertijd met verlaagde
aanmaak van IL-6 in de vaatwand. IL-6 knockout
muizen werden gebruikt om de regulerende rol
van IL-6 in haptoglobine expressie te bevestigen.
De expressie van haptoglobine was echter nor-
maal in IL-6 knockout muizen, duidend op
backup mechanisme voor de regulatie van hapto-
globine expressie.
Cel migratie en remodeleren van de extracellulaire
matrix zijn belangrijke tijdens meerdere fysiolo-
gische en pathologische processen. Omdat
haptoglobine een belangrijke rol speelt tijdens
cel migratie en remodeleren van de extracellulaire
matrix hebben we in hoofdstuk 4 de locale pro-
ductie van haptoglobine onderzocht in twee
pathologische weefsels die gekenmerkt worden
door deze twee processen. Eerder hebben sero-
epidemiologische studies al aangetoond dat
artritis and kanker gekenmerkt worden door
verhoogde concentraties haptoglobine in het
serum. In deze studie tonen we aan dat locale
haptoglobine expressie verhoogd is in artritis and
kankerweefsel.
Er wordt algemeen aangenomen dat haptoglobine
vooral in de lever wordt aangemaakt. Het is echter
aangetoond dat ook andere weefsel dan de lever
haptoglobin kunnen synthetiseren. Aangezien
haptoglobine in hoge concentraties in het serum
aanwezig is, is de functie van locale haptoglobine
expressie nog niet bekend. In hoofdstuk 5
onderzoeken we of veranderingen in glycosylering
van haptoglobine de noodzaak van locale hapto-
globine aanmaak in de vaatwand kan verklaren.
Haptoglobine expressie en glycosylering werd
bestudeerd in gedotterde konijnen. Dotteren
leidde tot een verhoging van haptoglobine produc-
tie in de vaatwand in de eerste twee weken na
beschadiging terwijl de expressie in de lever gelijk
bleef. Er waren geen verschillen in glycosylering
van haptoglobine in de vaatwand voor en na
dotteren. Haptoglobine uit de vaatwand werd
echter wel anders geglycosyleerd dan haptoglo-
bine uit de lever en kon worden aangetoond in
het serum.
Het is al eerder beschreven dat glycosylering van
haptoglobine in het serum geassocieerd is met
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het ontstaan en de prognose van bepaalde
ziekten. In hoofdstuk 6 wordt de potentiële rol
onderzocht van haptoglobine glycosylering pa-
tronen in het serum als serum marker voor
atherosclerose. Er blijken geen verschillen te zijn
tussen totale serum haptoglobine concentraties
en serum glycosylering van haptoglobine in
patiënten met en zonder atherosclerose. Daar-
naast is geen relatie aangetoond van totale serum
haptoglobine concentraties en glycosyle-ring van
haptoglobin met de intima-media dikte van de
carotis, dat een maat is voor de mate van athero-
sclerose. Hieruit kunnen we concluderen dat de
haptoglobine glycosyleringspatronen in het
serum niet gebruikt kunnen worden als marker
voor atherosclerose.
Hoofdstuk 7 is een algemene discussie over de
resultaten van de voorafgaande studies.
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Ook al heb ik het niet altijd makkelijk gevonden
om dingen uit handen te geven, toch hebben veel
mensen een belangrijke bijdrage geleverd aan dit
proefschrift. Zonder jullie was ik nooit zo ver
gekomen, bij deze bedankt voor alle hulp.
Dominique, ik heb in de afgelopen jaren
ontzettend veel van je geleerd. Niet alleen qua
uitvoering van experimenten maar ook het door-
gaan en vertrouwen hebben in waar je mee bezig
bent. Je was altijd weer enthousiast en positief
gestemd waardoor je me toch weer wist te
stimuleren om door te gaan. Ook al liep het niet
altijd even soepeltjes, het heeft toch wel wat
moois opgeleverd. Denk je er echter in het vervolg
wel aan dat ik er niet meer ben als je de dag voor
een presentatie mosselen wilt gaan eten.
Gerard, als tweede copromotor ben je nauw
betrokken geweest bij alle facetten van dit
promotieonderzoek. Ook al heb ik je op het lab
zelf niet veel gezien, bij alles wat er gebeuren
moest nadat een experiment was uitgevoerd was
je zeer nadrukkelijk aanwezig. Vooral je heldere
kijk op de zaken, alle wijze opmerkingen en
statistische ‘trucjes’ zijn de afgelopen jaren zeer
welkom geweest.
Kees Borst, bedankt voor de mogelijkheid om
dit promotie onderzoek uit te voeren. Met name
het snelle nakijken van manuscripten heb ik altijd
zeer op prijs gesteld.
Astrid en Ineke, heel erg bedankt voor de gezellige
sfeer die altijd op het secretariaat hangt en de
gezellige kletspraatjes. Daarnaast hebben jullie
allerhande zaken altijd goed voor me weten te
regelen en soepeltjes laten verlopen.
Arjan, bedankt dat je altijd weer bereid was om
me met praktische problemen te helpen en dingen
voor me uit te zoeken.
Evelyn, zonder jou zouden al die operaties nooit
gedaan zijn. Dank je voor de vele konijnen die je
voor ons allemaal hebt geopereerd.
Mattie, onze reddende engel op computergebied.
In mijn ogen wist je werkelijk alles van computers
af. Heel erg bedankt voor het feit dat je altijd
weer tijd had en, nog belangrijker, bereid was om
me uit de brand te helpen als er iets misging.
Marion en Aryan, ondanks de vele geintjes over
wel of geen artsen in een lab hebben we toch veel
van elkaar kunnen leren. Aryan, ik denk nog steeds
met veel plezier terug aan dat bounty-eiland in
Maleisië, goede keus.
Anne, Ben, Chaylendra, Juan, Joris, Manon en
Saskia, thanks for all the fruitful discussions and
the nice atmosphere on the lab.
Chantal Velthuis, bedankt voor alle experimen-
ten die je me tijdens je stage uit handen hebt
genomen.
De MICABG groep wil ik bij deze bedanken
voor het aanleveren van de vele verse varkens-
vaten gedurende de afgelopen vier jaar. John, jij
met name ook bedankt voor die werkelijk unieke
ervaring die je een aantal van ons in de grotten
van Valkenburg hebt laten meemaken.
Het ICIN wil ik graag bedanken voor de geweldige
inbedding waar mijn promotie onderzoek deel
van uit maakte. Daarnaast wil ik met name Manja
bedanken voor het supersnel regelen en uitzoeken
van allerhande zaken die in de loop der jaren ter
sprake zijn gekomen.
Oom Pol, bedankt voor het regelen van het ont-
werpen van de kaft. Het ziet er erg mooi uit.
Paranimfen, jullie hebben allebei de afgelopen vier
jaar veel voor mij gedaan. Dank je dat jullie bereid
zijn me tijdens dit laatste onderdeel ook nog ter
zijde te staan. Ingrid, bijna tegelijkertijd begonnen
en bijna op dezelfde dag gepromoveerd. Jij zit
waarschijnlijk een stuk onrustiger bij mijn
promotie dan ik bij die van jou maar aan het
einde van de week zijn we toch maar mooi allebei
gepromoveerd. Ik heb het altijd een geruststellend
idee gevonden dat je maar één verdieping boven
me zat te pipetteren. Als er iets verkeerd ging
konden we altijd “even” samen theedrinken om
alle tegenslag van ons af te zetten. Joost, samen
proeven doen (ooh, bedoel ik een experiment!?)
zit er helaas niet meer in. Je hebt die vier jaar in
het lab heel erg gezellig weten te maken.
Verbazingwekkend, dat we naast het pipetpuntjes
schieten en de vele achtervolgingen binnen het
lab toch nog aardig wat werk hebben weten te
verzetten.
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Aafke, lieve zus, dank je voor alle interesse, steun
en het geduld dat je met mij hebt moeten hebben.
Papa en mama, jullie hebben je allebei altijd
ontzettend ingespannen om op de hoogte te
blijven van alles wat er zich tijdens mijn promotie
onderzoek afspeelde. Daarnaast hebben jullie me
altijd weten te stimuleren om door te gaan en
gesteund in de beslissingen die ik heb genomen.
Ik hoop dat jullie beseffen hoezeer ik dat weet te
waarderen. Hier is dan eindelijk het eindresultaat
van al mijn inspanningen.
Lieve Patrick, ik denk dat we in het begin geen
van beiden gedacht hebben dat die stage van jou
uiteindelijk het onderwerp van mijn proefschrift
zou opleveren. Dank je voor je luisterende oor,
de mentale steun en de praktische hulp die je me
zo vaak hebt gegeven.
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